Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1173081-96-3 | MDL No. : | MFCD09053337 |
Formula : | C8H13ClN2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZMDPNGUJHPRAMG-UHFFFAOYSA-N |
M.W : | 188.65 | Pubchem ID : | 43810451 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.38 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 51.63 |
TPSA : | 58.88 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.94 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.72 |
Log Po/w (WLOGP) : | 1.1 |
Log Po/w (MLOGP) : | 0.71 |
Log Po/w (SILICOS-IT) : | 1.99 |
Consensus Log Po/w : | 0.9 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.77 |
Solubility : | 3.22 mg/ml ; 0.0171 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.53 |
Solubility : | 5.51 mg/ml ; 0.0292 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.73 |
Solubility : | 0.347 mg/ml ; 0.00184 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.84 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With hydrogenchloride; hydrogen; palladium(II) hydroxide In methanol; water at 20℃; for 26 h; Inert atmosphere | To a solution of 4,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile (10.0 g, 67.5 mmol) in MeOH (1.50 L) and conc. HCl (30 mL) was added 10percent Pd(OH)2 (19 g) under N2 atmosphere. The N2 gas was displaced by H2 gas and the mixture was stirred for 26 hours at RT under hydrogen atmosphere. The H2 gas was displaced by N2 gas. The mixture was filtered through Celite, washed with MeOH and concentrated. The residue was triturated with EtOH, collected with Buchner funnel, and dried under vacuum pressure to give the titled compound as a white solid (11.5 g, 90percent). 1H NMR (400 MHz, DMSO-d6): δ ppm 11.86 (brs, 1H), 5.98 (s, 1H), 3.78 (m, 2H), 2.20 (s, 3H), 2.16 (s, 3H). |
51 g | Stage #1: for 48 h; Stage #2: With hydrogenchloride In water |
Intermediate 83-(Aminomethyl)-4,6-dim pyridinone hydrochloridePalladium on carbon (10percent) (3.24 g) was charged into a 2L dry Parr bottle and a small amount of acetic acid was added. Next added 4,6-dimethyl-2-oxo-l,2-dihydro- pyridine- 3-carbonitrile (30 g , 202.7 mmol), sodium acetate (30.75 g, 375.0 mmol), platinum oxide (0.218 g), and acetic acid (1 L).. The bottle was capped, placed on Parr apparatus, and shaken under an atmosphere of H2 (100 psi) for 2 days. The reaction mixture was filtered.The solvent was removed to give a residue, which was treated with 150 mL of cone. HCl, and the formed solids were filtered. The yellow filtrate was concentrated . To the crude compound was added 30 mL of cone. HCl and 150 mL EtOH, the contents cooled to 0 °C, and stirred at 0 °C for 2h. The formed solids were filtered, washed with cold EtOH, ether, and dried. The product was collected as 36 g. This batch was combined with other batches prepared on smaller scales and triturated with ether to give 51 g of pure compound.. 1H NMR (400 MHz, DMSO- 6) ? ppm 11.85 (br s,l H) 8.13 (br s, 3 H) 5.93 - 6.01 (m, 1 H) 3.72 - 3.80 (m, 2 H) 2.22 (s, 3 H) 2.16 (s, 3 H). |
36g | With platinum(IV) oxide; palladium 10% on activated carbon; hydrogen; sodium acetate In acetic acid for 48 h; | Palladium on carbon (10percent) (3.24 g) was charged into a 2 L dry Parr bottle and asmall amount of acetic acid was added. Next added 4,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile (30 g, 202.7 mmol), sodium acetate (30.75 g, 375.0 mmol),platinum oxide (0.218 g), and acetic acid (1 L) .. The bottle was capped, placed on Parrapparatus, and shaken under an atmosphere ofH2 (100 psi) for 2 days. The reaction mixture was filtered. The solvent was removed to give a residue, which was treated with150 mL of cone. HCl, and the formed solids were filtered. The yellow filtrate wasconcentrated. To the crude compound was added 30 mL of cone. HCl and 150 mL EtOH,the contents cooled to 0 °C, and stirred at 0 oc for 2h. The formed solids were filtered,washed with cold EtOH, ether, and dried. The product was collected as 36 g. This batchwas combined with other batches prepared on smaller scales and triturated with ether togive 51 g of pure compound. IH NMR (400 MHz, DMSO-d6) 8 ppm 11.85 (br s,l H) 8.13(br s, 3 H) 5.93-6.01 (m, 1 H) 3.72-3.80 (m, 2 H) 2.22 (s, 3 H) 2.16 (s, 3 H). |
51 g | Stage #1: for 48 h; Inert atmosphere Stage #2: With hydrogenchloride In ethanol; water at 0℃; for 2 h; Inert atmosphere |
Palladium on carbon (10percent) (3.24 g) was charged into a 2L dry Parr bottle and a small amount of acetic acid was added. Next added 4,6-dimethyl-2-oxo-1,2-dihydro-pyridine-3-carbonitrile (30 g, 202.7 mmol), sodium acetate (30.75 g, 375.0 mmol), platinum oxide (0.218 g), and acetic acid (1 L). The bottle was capped, placed on Parr apparatus, and shaken under an atmosphere of H2 (100 psi) for 2 days. The reaction mixture was filtered. The solvent was removed to give a residue, which was treated with 150 mL of conc. HCl, and the formed solids were filtered. The yellow filtrate was concentrated. To the crude compound was added 30 mL of conc. HCl and 150 mL EtOH, the contents cooled to 0° C., and stirred at 0° C. for 2 h. The formed solids were filtered, washed with cold EtOH, ether, and dried. The product was collected as 36 g. This batch was combined with other batches prepared on smaller scales and triturated with ether to give 51 g of pure compound. 1H NMR (400 MHz, DMSO-d6) δ ppm 11.85 (br s, 1H) 8.13 (br s, 3H) 5.93-6.01 (m, 1H) 3.72-3.80 (m, 2H) 2.22 (s, 3H) 2.16 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With hydrogenchloride In water at 100℃; for 6 h; | A solution of tert-butyl [(2-methoxy-4,6-dimethylpyridin-3-yl)methyl]carbamate (Cpd U, 140 g, 0.52 mol) in 6N HCl (500 mL) was heated at 100° C. and stirred for six hours. The reaction mixture was concentrated and the residue was re-crystallized with EtOH to afford the title compound (Cpd V, 77 g, 55percent) as hydrochloride salts. 1H NMR (400 MHz, D2O) δ 6.31 (s, 1H), 4.11 (s, 2H), 2.31-2.30 (s, 6H); MS 175.1 [M+Na]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | Stage #1: With triethylamine In dimethyl sulfoxide at 15 - 25℃; for 0.5 h; Stage #2: With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dimethyl sulfoxide at 20℃; for 16 h; Stage #3: With triethylamine In water; dimethyl sulfoxide at 19 - 30℃; for 4 h; |
N-((4,6-dimethyl-2-oxo-l,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H- pyran-4-yl)amino)-4-methyl-4 '-(morpholinomethyl)- [1,1 '-biphenyl] -3-carboxamide (Compound I) A mixture of 5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'- (morpho linomethyl)-[ 1,1 '-biphenyl] -3 -carboxylic acid (540 g, 1.23 mol) and 3-(aminomethyl)- 4,6-dimethyl-dihydro-pyridin-2(lH)-one hydrochloride (279 g, 1.48 mol) was suspended in DMSO (2.70 L) and treated with triethylamine (223 ml, 1.60 mol). The mixture was stirred at 25 °C for 30 min and treated with EDC-HC1 (354 g, 1.85 mol) and HOBT hydrate (283 g, 1.85 mol). The reaction mixture was stirred at rt for 16 h. After addition of triethylamine (292 ml, 2.09 mol), the mixture was cooled to 15 °C, diluted with water (10.1 L) maintaining the temperature below 30 °C, and stirred at 19-25 °C for 4 h. The resulting precipitate was filtered, washed twice with water (2.70 L), and dried under vacuum to give a crude product (695 g, wt-wt analysis = 78percent). For the further purification of the product, recrystallization was conducted. A crude product (20.00 g, 34.92 mmol) was suspended in a mixture of ethanol (190 ml) and water (10.00 ml) and heated to 75°C until a clear solution was obtained. The solution was allowed to cool to rt overnight. The precipitate was filtered, washed twice with a mixture of ethanol (30.0 ml) and water (30.0 ml), and dried under vacuum at 35 °C to give the title compound as an off white solid (14.0 g, 70percent recovery from the crude and 90percent> yield based on wt-wt assay). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96.9% | Add 5.0g (0.034mol) to a 500mL single-mouth bottle4,6-dimethyl-3-cyanopyrimidin-2-one,250mL of methanol, not fully soluble,25mL 25% ammonia water,About 5.0g of nickel, replaced by argon three times,The hydrogen was replaced three times, and the temperature was raised to 50 C. After 11 h of reaction, the TLC reaction was complete.Stop the reaction and filter the solution through diatomaceous earth.The filtrate was evaporated to dryness to give 6.3 g, m.Dissolve the product with methanol,Placed in an ice salt bath,20mL of 4N hydrochloric acid ethanol solution was added dropwise with stirring.After the drop,After stirring for 1 h in an ice bath, a large amount of white solid was precipitated, which was filtered with suction to give a white solid.Wash twice with ethanol, suction filtration,Dry to give 5.0 g of a white solid.The yield was 96.9%. | |
90% | With hydrogenchloride; hydrogen; palladium(II) hydroxide; In methanol; water; at 20℃; for 26h;Inert atmosphere; | To a solution of 4,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile (10.0 g, 67.5 mmol) in MeOH (1.50 L) and conc. HCl (30 mL) was added 10% Pd(OH)2 (19 g) under N2 atmosphere. The N2 gas was displaced by H2 gas and the mixture was stirred for 26 hours at RT under hydrogen atmosphere. The H2 gas was displaced by N2 gas. The mixture was filtered through Celite, washed with MeOH and concentrated. The residue was triturated with EtOH, collected with Buchner funnel, and dried under vacuum pressure to give the titled compound as a white solid (11.5 g, 90%). 1H NMR (400 MHz, DMSO-d6): delta ppm 11.86 (brs, 1H), 5.98 (s, 1H), 3.78 (m, 2H), 2.20 (s, 3H), 2.16 (s, 3H). |
85% | Dissolve 10% Pd/C (324 mg) in a small amount of acetic acid.Add raw material SI (3 · 00g, 20 · 25mmol), AcONa(3 · 08g, 37 · 55mmol), Pt02 (30mg) and 100mL of acetic acid were hydrogenated at 100 psi H2.After 48 hours, the diatomaceous earth was filtered, the solvent was evaporated, 15 mL of concentrated hydrochloric acid was added, and then filtered, the filtrate was sifted, and 3 mL of concentrated hydrochloric acid and 15 mL of absolute ethanol were added, and the mixture was stirred under ice bath. After a period of time, solids were precipitated, after 2 hours. Filtration, cold ethanol wash, cold ether wash, yellowish white solid S2(3.258, yield 85%) |
Intermediate 1 3-(Aminomethyl)-4,6-dimethyl-2(lH)-pyridinone hydrochloride Palladium on carbon (10%) (3.24 g) was charged into a 2L dry Parr bottle and a small amount of acetic acid was added. Next added 4,6-dimethyl-2-oxo-l ,2-dihydro- pyridine-3- carbonitrile (30 g , 202.7 mmol), sodium acetate (30.75 g, 375.0 mmol), platinum oxide (0.218 g), and acetic acid (1 L).. The bottle was capped, placed on Parr apparatus, and shaken under an atmosphere of ¾ (100 psi) for 2 days. The reaction mixture was filtered. The solvent was removed to give a residue, which was treated with 150 mL of cone. HCl, and the formed solids were filtered. The yellow filtrate was concentrated . To the crude compound was added 30 mL of cone. HCl and 150 mL EtOH, the contents cooled to 0 C, and stirred at 0 C for 2h. The formed solids were filtered, washed with cold EtOH, ether, and dried. The product was collected as 36 g. This batch was combined with other batches prepared on smaller scales and triturated with ether to give 51 g of pure compound.. 1H NMR (400 MHz, DMSO- 6) delta ppm 1 1.85 (br s, l H) 8.13 (br s, 3 H) 5.93 - 6.01 (m, 1 H) 3.72 - 3.80 (m, 2 H) 2.22 (s, 3 H) 2.16 (s, 3 H). | ||
Intermediate 13-(Aminomethyl)-4,6-dimethyl-2(l//)-pyridinone hydrochloride Palladium on carbon (10%) (3.24 g) was charged into a 2L dry Parr bottle and a small amount of acetic acid was added. Next added 4,6-dimethyl-2-oxo- 1 ,2-dihydro- pyridine-3-carbonitrile (30 g , 202.7 mmol), sodium acetate (30.75 g, 375.0 mmol), platinum oxide (0.218 g), and acetic acid (1 L).. The bottle was capped, placed on Parr apparatus, and shaken under an atmosphere of H2 (100 psi) for 2 days. The reaction mixture was filtered. The solvent was removed to give a residue, which was treated with 150 mL of cone. HC1, and the formed solids were filtered. The yellow filtrate was concentrated . To the crude compound was added 30 mL of cone. HC1 and 150 mL EtOH, the contents cooled to 0 C, and stirred at 0 C for 2h. The formed solids were filtered, washed with cold EtOH, ether, and dried. The product was collected as 36 g. This batch was combined with other batches prepared on smaller scales and triturated with ether to give 51 g of pure compound.. lH NM (400 MHz, DMSO- | ||
51 g | Intermediate 83-(Aminomethyl)-4,6-dim pyridinone hydrochloridePalladium on carbon (10%) (3.24 g) was charged into a 2L dry Parr bottle and a small amount of acetic acid was added. Next added 4,6-dimethyl-2-oxo-l,2-dihydro- pyridine- 3-carbonitrile (30 g , 202.7 mmol), sodium acetate (30.75 g, 375.0 mmol), platinum oxide (0.218 g), and acetic acid (1 L).. The bottle was capped, placed on Parr apparatus, and shaken under an atmosphere of H2 (100 psi) for 2 days. The reaction mixture was filtered.The solvent was removed to give a residue, which was treated with 150 mL of cone. HCl, and the formed solids were filtered. The yellow filtrate was concentrated . To the crude compound was added 30 mL of cone. HCl and 150 mL EtOH, the contents cooled to 0 C, and stirred at 0 C for 2h. The formed solids were filtered, washed with cold EtOH, ether, and dried. The product was collected as 36 g. This batch was combined with other batches prepared on smaller scales and triturated with ether to give 51 g of pure compound.. 1H NMR (400 MHz, DMSO- 6) ? ppm 11.85 (br s,l H) 8.13 (br s, 3 H) 5.93 - 6.01 (m, 1 H) 3.72 - 3.80 (m, 2 H) 2.22 (s, 3 H) 2.16 (s, 3 H). | |
36g | With platinum(IV) oxide; palladium 10% on activated carbon; hydrogen; sodium acetate; In acetic acid; under 5171.62 Torr; for 48h; | Palladium on carbon (10%) (3.24 g) was charged into a 2 L dry Parr bottle and asmall amount of acetic acid was added. Next added 4,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile (30 g, 202.7 mmol), sodium acetate (30.75 g, 375.0 mmol),platinum oxide (0.218 g), and acetic acid (1 L) .. The bottle was capped, placed on Parrapparatus, and shaken under an atmosphere ofH2 (100 psi) for 2 days. The reaction mixture was filtered. The solvent was removed to give a residue, which was treated with150 mL of cone. HCl, and the formed solids were filtered. The yellow filtrate wasconcentrated. To the crude compound was added 30 mL of cone. HCl and 150 mL EtOH,the contents cooled to 0 C, and stirred at 0 oc for 2h. The formed solids were filtered,washed with cold EtOH, ether, and dried. The product was collected as 36 g. This batchwas combined with other batches prepared on smaller scales and triturated with ether togive 51 g of pure compound. IH NMR (400 MHz, DMSO-d6) 8 ppm 11.85 (br s,l H) 8.13(br s, 3 H) 5.93-6.01 (m, 1 H) 3.72-3.80 (m, 2 H) 2.22 (s, 3 H) 2.16 (s, 3 H). |
51 g | Palladium on carbon (10%) (3.24 g) was charged into a 2L dry Parr bottle and a small amount of acetic acid was added. Next added 4,6-dimethyl-2-oxo-1,2-dihydro-pyridine-3-carbonitrile (30 g, 202.7 mmol), sodium acetate (30.75 g, 375.0 mmol), platinum oxide (0.218 g), and acetic acid (1 L). The bottle was capped, placed on Parr apparatus, and shaken under an atmosphere of H2 (100 psi) for 2 days. The reaction mixture was filtered. The solvent was removed to give a residue, which was treated with 150 mL of conc. HCl, and the formed solids were filtered. The yellow filtrate was concentrated. To the crude compound was added 30 mL of conc. HCl and 150 mL EtOH, the contents cooled to 0 C., and stirred at 0 C. for 2 h. The formed solids were filtered, washed with cold EtOH, ether, and dried. The product was collected as 36 g. This batch was combined with other batches prepared on smaller scales and triturated with ether to give 51 g of pure compound. 1H NMR (400 MHz, DMSO-d6) delta ppm 11.85 (br s, 1H) 8.13 (br s, 3H) 5.93-6.01 (m, 1H) 3.72-3.80 (m, 2H) 2.22 (s, 3H) 2.16 (s, 3H). | |
5 g | The titledproduct was obtained from carbonitrile B7c according to the general procedure describedpreviously for the reduction reaction of carbonitrile as a light yellow solid (6.3 g). The crude product was dissolved with menthol in ice bath below 0 C, the 4 N hydrogenchloride ethanol solution (20 mL) was added dropwise. The stirring was continued for 60min, and the solid filtered off and washed with ethanol. After drying, hydrochloride saltwas obtained as a white solid (5.0 g, 97%). 1H NMR (600 MHz, DMSO-d6) delta (ppm): 11.84(br, 1H), 8.04 (s, 3H), 5.97 (s, 1H), 3.77 (s, 2H), 2.21 (s, 3H), 2.16 (s, 3H). Compounds B1~B5were obtained from different carbonitrile (B6a-c, B7a-b) to provide the correspondingproducts according to the general procedure described previously for the reductionreaction of carbonitrile. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; In N,N-dimethyl-formamide; at 20℃;Inert atmosphere; | b) 6-(2-Aminoethyl)-N-[(4,6-dimethyl-2-oxo-l,2-dihydro-3-pyridinyl)methyl]-3-methyl-l- (1 -methylethyl)- lH-indole-4-carboxamide hydrochloride salt To a stirred suspension of 6-[2-([(l,l-dimethylethyl)oxy]carbonyl}amino)ethyl]-3- methyl- l-(l-methylethyl)-lH-indole-4-carboxylic acid (500 mg, 1.387 mmol), 3- (aminomethyl)-4,6-dimethyl-2(lH)-pyridinone HC1 salt (340 mg, 1.802 mmol), HO At (245 mg, 1.800 mmol) in DMF (20 mL) was added N-methylmorpholine (200 mu, 1.819 mmol) and EDC free base (280 mg, 1.804 mmol). The reaction was stirred overnight at RT. LCMS showed that the reaction was complete. The reaction was evaporated to dryness and purified by silica gel chromatography (Analogix, SF25-40g, 0 to 10% CH2C12 / 20%(5% NH4OH in MeOH) in CH2C12). The pure fractions were combined and evaporated to dryness. Triturated with 50%) MeOH in water, filtered and dried under vacuum to give the Boc protected product as an off- white solid. The Boc protected product was suspended in a small volume of MeOH (2 mL) and treated with 4 N HC1 in dioxane (25 mL) and stirred at RT for 1 hr. LCMS showed that the reaction was complete. The reaction was evaporated to dryness, triturated with Et20, filtered and dried under vacuum to give the product 6-(2-aminoethyl)-N-[(4,6- dimethyl-2-oxo- 1 ,2-dihydro-3 -pyridinyl)methyl]-3 -methyl- 1 -( 1 -methylethyl)- 1 H-indole-4- carboxamide (460 mg, 1.067 mmol, 77% yield) as an off-white solid. 1H NMR (400MHz ,DMSO-d6 + D20) delta 8.05 (t, J= 5.2 Hz, 1 H), 8.00 (br. s., 2 H), 7.39 (d, J= 1.0 Hz, 1 H),7.25 (s, 1 H), 6.86 (d, J= 1.3 Hz, 1 H), 5.93 (s, 1 H), 4.69 (dt, J= 6.6, 13.3 Hz, 1 H), 4.34 (d, J= 5.1 Hz, 2 H), 3.06 (dd, J= 5.8, 7.6 Hz, 2 H), 3.01 - 2.91 (m, 2 H), 2.25 (s, 3 H), 2.13 (s, 3H), 2.12 (s, 3 H), 1.41 (d, J= 6.8 Hz, 6 H). MS(ES)+ m/e 394.9 [M+H]+. | |
With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In N,N-dimethyl-formamide; at 20℃;Inert atmosphere; | To a stirred suspension of 6-[2-([(1,1-dimethylethyl)oxy]carbonyl}amino)ethyl]-3-methyl-1-(1-methylethyl)-1H-indole-4-carboxylic acid (500 mg, 1.387 mmol), 3-(aminomethyl)-4,6-dimethyl-2(1H)-pyridinone HCl salt (340 mg, 1.802 mmol), HOAt (245 mg, 1.800 mmol) in DMF (20 mL) was added N-methylmorpholine (200 muL, 1.819 mmol) and EDC free base (280 mg, 1.804 mmol). The reaction was stirred overnight at RT. LCMS showed that the reaction was complete. The reaction was evaporated to dryness and purified by silica gel chromatography (Analogix, SF25-40g, 0 to 10% CH2Cl2/20% (5% NH4OH in MeOH) in CH2Cl2). The pure fractions were combined and evaporated to dryness. Triturated with 50% MeOH in water, filtered and dried under vacuum to give the Boc protected product as an off-white solid. The Boc protected product was suspended in a small volume of MeOH (2 mL) and treated with 4 N HCl in dioxane (25 mL) and stirred at RT for 1 hr. LCMS showed that the reaction was complete. The reaction was evaporated to dryness, triturated with Et2O, filtered and dried under vacuum to give the product 6-(2-aminoethyl)-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-(1-methylethyl)-1H-indole-4-carboxamide (460 mg, 1.067 mmol, 77% yield) as an off-white solid. 1H NMR (400 MHz, DMSO-d6+D2O) delta 8.05 (t, J=5.2 Hz, 1H), 8.00 (br. s., 2H), 7.39 (d, J=1.0 Hz, 1H), 7.25 (s, 1H), 6.86 (d, J=1.3 Hz, 1H), 5.93 (s, 1H), 4.69 (dt, J=6.6, 13.3 Hz, 1H), 4.34 (d, J=5.1 Hz, 2H), 3.06 (dd, J=5.8, 7.6 Hz, 2H), 3.01-2.91 (m, 2H), 2.25 (s, 3H), 2.13 (s, 3H), 2.12 (s, 3H), 1.41 (d, J=6.8 Hz, 6H). MS(ES)+ m/e 394.9 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64.9% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; In N,N-dimethyl-formamide; at 20℃; for 4h;Inert atmosphere; | c) 6-{3-[(Dimethylamino)methyl]-4-fluorophenyl}-N-[(4,6-dimethyl-2-oxo-l,2-dihydro-3- pyridinyl)methyl] -3 -meth l- 1 -( 1 -methylethyl)- 1 H-indole-4-carboxamide To a stirred suspension of 6- {3-[(dimethylamino)methyl]-4-fluorophenyl} -3-methyl-1-(1 -methylethyl)- lH-indole-4-carboxylic acid (210 mg, 0.570 mmol), 3-(aminomethyl)-4,6- dimethyl-2(lH)-pyridinone HCl salt (140 mg, 0.742 mmol) and HO At (100 mg, 0.735 mmol) in DMF (15 mL) was added N-methylmorpholine (82 mu, 0.746 mmol) and EDC free base (110 mg, 0.709 mmol). The reaction was stirred for 4 h at RT and concentrated to near dryness under vacuum. Water was added till the product ppt. out. The suspension was triturated, filtered, rinsed with cold water water then dried under vacuum to give the product 6- {3-[(dimethylamino)methyl]-4-fluorophenyl} -N-[(4,6-dimethyl-2-oxo- 1 ,2-dihydro-3- pyridinyl)methyl] -3 -methyl- 1-(1 -methylethyl)- lH-indole-4-carboxamide (186 mg, 0.370 mmol, 64.9% yield) as a light tan solid.1H NMR (400MHz ,DMSO-d6) delta = 11.47 (br. s., 1 H), 8.15 (t, J= 4.9 Hz, 1 H), 8.04 (d, J= 5.3 Hz, 1 H), 7.90 - 7.86 (m, 1 H), 7.39 (t, J= 9.2 Hz, 1 H), 7.35 (s, 1 H), 7.27 (d, J= 1.3 Hz, 1 H), 5.87 (s, 1 H), 4.88 (dt, J= 6.6, 13.3 Hz, 1 H), 4.36 (d, J= 5.1 Hz, 2 H), 4.26 (br. s., 2 H), 2.69 (s, 6 H), 2.24 (s, 3 H), 2.17 (s, 3 H), 2.11 (s, 3 H),1.44 (d, J= 6.6 Hz, 6 H). MS(ES)+ m/e 503.0 [M+H]+. |
64.9% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In N,N-dimethyl-formamide; at 20℃; for 4h;Inert atmosphere; | To a stirred suspension of 6-{3-[(dimethylamino)methyl]-4-fluorophenyl}-3-methyl-1-(1-methylethyl)-1H-indole-4-carboxylic acid (210 mg, 0.570 mmol), 3-(aminomethyl)-4,6-dimethyl-2(1H)-pyridinone HCl salt (140 mg, 0.742 mmol) and HOAt (100 mg, 0.735 mmol) in DMF (15 mL) was added N-methylmorpholine (82 mul, 0.746 mmol) and EDC free base (110 mg, 0.709 mmol). The reaction was stirred for 4 h at RT and concentrated to near dryness under vacuum. Water was added till the product ppt. out. The suspension was triturated, filtered, rinsed with cold water then dried under vacuum to give the product 6-{3-[(dimethylamino)methyl]-4-fluorophenyl}-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-(1-methylethyl)-1H-indole-4-carboxamide (186 mg, 0.370 mmol, 64.9% yield) as a light tan solid. 1H NMR (400 MHz, DMSO-d6) delta=11.47 (br. s., 1H), 8.15 (t, J=4.9 Hz, 1H), 8.04 (d, J=5.3 Hz, 1H), 7.90-7.86 (m, 1H), 7.39 (t, J=9.2 Hz, 1H), 7.35 (s, 1H), 7.27 (d, J=1.3 Hz, 1H), 5.87 (s, 1H), 4.88 (dt, J=6.6, 13.3 Hz, 1H), 4.36 (d, J=5.1 Hz, 2H), 4.26 (br. s., 2H), 2.69 (s, 6H), 2.24 (s, 3H), 2.17 (s, 3H), 2.11 (s, 3H), 1.44 (d, J=6.6 Hz, 6H). MS(ES)+ m/e 503.0 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dimethyl sulfoxide; at 20℃; | Step 2: 6-bromo-l-cyclopentyl-lH-indazole-4-carboxylic acid (1.44 g, 4.61 mmol), 3-(aminomethyl)- 4,6-dimethyl-2(lH)-pyridinone hydrochloride (1.138 g, 6.03 mmol), N-[3-(dimethylamino)propyl]- N'-ethylcarbodiimide hydrochloride (1.335 g, 6.96 mmol), and 3H-[l,2,3]triazolo[4,5-b]pyridin-3-ol hydrate (1.073 g, 6.96 mmol) were suspended in DMSO (8.00 mL), followed by N-methylmorpholine (2.82 g, 27.8 mmol). The reaction mixture was stirred at room temperature overnight to afford a slurry. The slurry was diluted with DMSO (10 mL) and added dropwise to a ice-chilled aqueous solution of IN Na2CC>3 (50 ml) and water (200 mL), and stirred rapidly for 30 min. The precipitate was collected by vacuum filtration and washed with water. The cake was dried in the vacuum oven at 60 C overnight (16h). The title compound was obtained as a pale yellow-white solid (2.05 g, 98 % yield). lB NMR (400 MHz, DMSO-56) delta 11.50 (br. s., 1H), 8.64 (br. s., 1H), 8.37 (s, 1H), 8.20 (s,1H), 7.70 (d, J= 1.52 Hz, 1H), 5.89 (s, 1H), 5.22 (quin, J = 7.01 Hz, 1H), 4.34 (d, J = 4.55 Hz, 2H), 2.20 (s, 3H), 2.13 (s, 3H), 2.06 - 2.11 (m, 2H), 1.91 - 2.03 (m, 2H), 1.80 - 1.91 (m, 2H), 1.61 - 1.75 (m, 2H). LC-MS(ES) [M+H]+ 443.0. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
27% | [0966] 3-[(2R*,4R*,6S*)-l-Benzyl-2,6-dimethylpiperidin-4-yl](ethyl)amino}-N-[(4,6- dimethyl-2-oxo-l,2-dihydropyridin-3-yl)methyl]-2-methyl-5-(trifluoromethyl)benzamide[0967] To a stirred solution of methyl 3-{ [(2R, 6S)- l -benzyl-2,6-dimethylpiperidin -4- yl](ethyl)amino}-2-methyl-5-(trifluoromethyl)benzoate ( 106 mg, 0.228 mmol) in ethanol (2.0 mL) was added aq. NaOH (5 M, 91 .2 ul, 0.456 mmol). The reaction mixture was stirred at 80 C for 1 .5 hours. After cooling to rt, solvent was removed in vacuo and dried under reduced pressure. To a stirred solution of this residue and 3-(aminomethyl)-4,6-dimethyl-l ,2- dihydropyridin-2-one HC1 salt (55.9 mg, 0.297 mmol) in DMSO (2 mL) was added Hunig's base (199 ul, 1 .14 mmol) and PyBOP (178 mg, 0.342 mmol). The reaction mixture was stirred at rt for 4 hours. The reaction mixture was quenched with water. The content was extracted with ethylacetate. The organic layer was washed with water twice and brine. The organic layer was dried over MgS04 and filtered. The filtrate was concentrated in vacuo. The residue was purified by silica gel column chromatography (NH Si02, ethylacetate/MeOH=50/l to 40/1 ) to give the titled compound as a colorless oil (35.6 mg, 27% yield). -NMR (400 MHz, CDC13)5ppm; 7.34-7.08 (m, 7H), 5.96 (s, 1 H), 4.54 (d, J = 6.0Hz, 2H), 3.81 (s, 2H), 3.53 (m, 1 H), 2.99-2.91 (m, 2H), 2.81 (m, 2H), 2.41 (s, 3H), 2.24 (s, 3H), 2.20 (s, 3H), 1 .82-1 .47 (m, 4H), 1 .00 (d, J= 6.4Hz, 6H), 0.81 (t, J= 6.8Hz, 3H); MS(ES) [M+H] 583.0. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In dimethyl sulfoxide; at 23℃; for 19h; | [0965] To a stirred solution of crude carboxylic acid sodium salt and 3-(aminomethyl)-4,6- dimethyl- l ,2-dihydropyridin-2-one HC1 salt ( 125 mg, 0.664 mmol) in DMSO (5 mL) was added PyBOP (398 mg, 0.766 mmol) and Hunig's base (445 ul, 2.55 mmol). The reaction mixture was stirred at 23C for 19 hours. The reaction mixture was quenched with water and extracted with ethylacetate. The organic layer was washed with water (twice) and brine. The organic layer was dried over MgS04 and filtered. The combined organic layer was concentrated in vacuo. The residue was purified by silica gel column chromatography (NH-Si02;ethylacetate/MeOH=50/l -8/l ) to give the titled compound as a white amorphous (267 mg, 90% yield). -NMR (400 MHz, CDC13) 5ppm; 7.14-7.36 (m, 8H), 5.94 (s, 1 H), 4.53-4.56 (m, 2H), 3.85 (d, J= 14.0 Hz, 1H), 3.58 (d, J= 14.0 Hz, 1 H), 3.02-3.14 (m, 4H), 2.72-2.80 (m, 1H), 2.40 (s, 3H), 2.32 (s, 3H), 2.21 (s, 3H), 1 .32- 1 .82 (m, 4H), 1.05 (d, J= 6.4 Hz, 3H), 0.92 (d, J= 6.8 Hz, 3H), 0.84 (t, J= 6.8 Hz, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
79% | 0988] 3-[(2R,4R,6S)-l-Benzyl-2,6-dimethylpiperidin-4-yl](ethyl)amino}-N-[(4,6- dimethyl-2-oxo-l,2-dihydropyridin-3-yl)methyl)-5-fluoro-2-methylbenzamide[0989] To a stirred solution of methyl 3-{ [(2R,4R,6S)-l -benzyl-2,6-dimethylpiperidin-4-yl] (ethyl)amino}-5-fluoro-2-methylbenzoate (48.5 mg, 0.1 18 mmol) in ethanol (1.5 mL) was added aq. NaOH (5 M, 47.0 ul, 0.235 mmol). The reaction mixture was stirred at 80 C for 1 .5 hours. After cooling to rt, solvent was removed in vacuo and dried under reduced pressure. To a stirred solution of this residue and 3-(aminomethyl)-4,6-dimethyl - l ,2-dihydropyridin-2-one HC1 salt (28.8 mg, 0.153 mmol) in DMSO ( 1 mL) was added PyBOP (91 .8 mg, 0.176 mmol) and Hunig's base (102 ul, 0.588 mmol). The reaction mixture was stirred at 23C for 13.5 hours. The reaction mixture was quenched with water, and the mixture was extracted with ethylacetate. The organic layer was washed with water (2 10 mL) and brine (1 x 10 mL). The organic layer was dried over MgS04, filtered and the filtrate was concentrated in vacuo. The residue was purified by silica gel column chromatography (NH Si02, ethylacetate/MeOH=50/l to 8/1 ) to give title compound as a white solid (50.1 mg, 79% yield). MS(ES) [M+H] 533.3. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In dimethyl sulfoxide; at 23℃; for 5h; | [0987] To a stirred solution of crude carboxylic acid sodium salt and 3-(aminomethyl)-4,6- dimethyl-l ,2-dihydropyridin-2-one HC1 salt (165 mg, 0.874 mmol) in DMSO (5 mL) was added PyBOP (525 mg, 1.01 mmol) and Hunig's base (586 ul, 3.36 mmol). The reaction mixture was stirred at 23 C for 5 hours. The reaction mixture was quenched with water and extracted with ethylacetate. The organic layer was washed with water (2 x 10 mL) and brine ( 1 x 10 mL). The organic layer was dried over MgS04 and filtered and the filtrate concentrated in vacuo. The residue was purified by silica gel column chromatography (NH-Si02; ethylacetate only to ethylacetate/MeOH=50/ 1 -8/1 ) to give titled compound as a white solid (378 mg, quantitative yield). TI MR (400 Vll Iz. CDC ) 5ppm; 7.20-7.38 (m. 51 1). 7.02-7. 10 (m, 1 1 1), 6.80-6.84 (m, 1 H), 6.73-6.78 (m, 1 H), 5.93 (s, 1 H), 4.51 (d, J= 6.0 Hz, 2H), 3.85 (d, J= 10.0 Hz, 1 H), 3.38 (d, J = 10.0 Hz, 1 H), 3.01 -3.05 (m, 4H), 2.67-2.81 (m, 1 H), 2.40 (s, 3H), 2.23 (s, 3H), 2.23 (s, 3H), 1 .52-1 .83 (m, 3H), 1 .32- 1 .39 (m, 1 H), 1 .05 (d, J = 6.4 Hz, 3H), 0.93 (d, J = 6.8 Hz, 3H), 0.84 (t, J= 6.8 Hz, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dimethyl sulfoxide; at 20℃; for 48h;Inert atmosphere; Sealed tube; | Example 36V-[(4,6-Dimethyl-2-oxo-l,2-dihydro-3-pyridinyl)methyl]-6-methyl-l-(l-methylethyl)- lH-pyrazolo -6]pyridine-4-carboxamideIn a 25 mL sealable tube under nitrogen were combined 6-methyl-l-(l- methylethyl)-lH-pyrazolo [3, 4-b] pyridine-4-carboxylic acid (60 mg, 0.27 mmol) and 3- (aminomethyl)-4,6-dimethyl-2(lH)-pyridinone.HCl (62 mg, 0.33 mmol) in DMSO (3 mL). l-hydroxy-7-azabenzotriazole (56 mg, 0.41 mmol) was added and the resulting mixture was degassed with nitrogen for 10 minutes. N-methylmorpholine (0.11 ml, 0.96 mmol) and EDC (79 mg, 0.41 mmol) were added, the vessel was sealed, and the light brown mixture was stirred at room temperature for 2 days. Next added 2 mL of water and the mixture was stirred for 10 min. Solids that precipitated were sonicated, and allowed to stand at room temperature for 10 min. The contents were filtered, washed with water, and dried to afford the title compound (68 mg, 68%) as a light pink solid. LCMS E-S (M+H) = 354.3. 1H NMR (400 MHz, DMSO-d6) ? ppm 11.54 (s, 1 H), 8.69 (t, J=4.80 Hz, 1 H), 8.26 (s, 1 H), 7.46 (s, 1 H), 5.89 (s, 1 H), 5.20 (quin, J=6.69 Hz, 1 H), 4.36 (d, J=5.05 Hz, 2 H), 2.63 (s, 3 H), 2.21 (s, 3 H), 2.13 (s, 3 H), 1.48 (d, J=6.57 Hz, 6 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dimethyl sulfoxide; at 20℃; for 48h;Sealed tube; Inert atmosphere; | Example 38V-[(4,6-Dimethyl-2-oxo-l,2-dihydro-3-pyridinyl)methyl]-l-(l-methylethyl)-6-phenyl- lH-pyrazo -6]pyridine-4-carboxamideIn a 25 mL sealable tube under nitrogen were combined l-(l-methylethyl)-6- phenyl-lH-pyrazolo[3,4-b]pyridine-4-carboxylic acid (70 mg, 0.25 mmol) and 3- (aminomethyl)-4,6-dimethyl-2(lH)-pyridinone.HCl (56.3 mg, 0.3 mmol) in DMSO (3 mL). l-hydroxy-7-azabenzotriazole (51 mg, 0.37 mmol) was added and the resulting mixture was degassed with nitrogen for 10 min. N-methylmorpholine (0.1 ml, 0.87 mmol) and EDC (72 mg, 0.37 mmol) were added, the vessel was sealed, and the bright yellow mixture was stirred at room temperature for 2 days. Next added 2 mL of water, and the contents were stirred for 10 min. Solids that precipitated were sonicated, and allowed to stand at room temperature for 10 min. The reaction contents were filtered and washed with water. The solid was treated with 2 mL of EtOH, sonicated and heated, and then allowed to cool to room temperature. The contents were filtered, washed with water and dried to afford the title compound (74 mg, 70%) as a white solid. LCMS E-S (M+H) = 416.3. 1H NMR (400 MHz, DMSO-d6) ? ppm 11.58 (s, 1 H), 8.98 (t, J=4.80 Hz, 1 H), 8.38 (s, 1 H), 8.25 - 8.30 (m, 2 H), 8.17 (s, 1 H), 7.49 - 7.59 (m, 3 H), 5.91 (s, 1 H), 5.30 - 5.38 (m, 1 H), 4.42 (d, J=4.80 Hz, 2 H), 2.23 (s, 3 H), 2.13 (s, 3 H), 1.55 (d, J=6.57 Hz, 6 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dimethyl sulfoxide; at 20℃;Inert atmosphere; | Example 26-Chloro- V-[(4,6-dimethyl-2-oxo-l,2-dihydro-3-pyridinyl)methyl]-3-methyl-l-(l- methylethyl)-lH-pyraz -6]pyridine-4-carboxamide6-chloro-3 -methyl- 1 -( 1 -methylethyl)- 1 H-pyrazolo [3 ,4-b]pyridine-4-carboxylic acid ( 1324 mg, 5.22 mmol), 3-(aminomethyl)-4,6-dimethyl-2(lH)-pyridinone. HC1 (1329 mg, 7.05 mmol) and l-hydroxy-7-azabenzotriazole (1066 mg, 7.83 mmol) were stirred in 10 mL of DMSO for 10 min under nitrogen. N-methylmorpholine (2.3 mL, 20.88 mmol) was added along with EDC (1501 mg, 7.83 mmol) and the mixture became dark yellow. After a few hours solids precipitated and the contents became very thick, so 10 mL DMSO was added to facilitate stirring, The contents were stirred at RT overnight. Next added ice-water and then 10% K2CO3 (pH ~ 8-9). The contents were stirred at RT for 30 min and then allowed to stand at RT for another 30 min. The contents were filtered, washed with water, and dried in vacuo. The title compound was collected as 1.67g (81 >) and used without further purification. 1H NMR (400 MHz, DMSO-d6) ? ppm 1.44 (d, 6 H), 2.12 (s, 3 H), 2.22 (s, 3 H), 2.40 (s, 3 H), 4.34 (d, J=5.05 Hz, 2 H), 5.05 (quin, J=6.63 Hz, 1 H), 5.88 (s, 1 H), 7.16 (s, 1 H), 8.78 (t, J=4.93 Hz, 1 H), 11.53 (br. s., 1 H). LCMS E-S (M+H) = 388.1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
27% | Example 1233-Bromo- V-[(4,6-dimethyl-2-oxo-l,2-dihydro-3-pyridinyl)methyl]-l-(l-methylethyl)- iyl-l -pyrazolo[3,4-6]pyridine-4-carboxamide3-Bromo- 1 -(1 -methylethyl)-6-phenyl- lH-pyrazolo[3,4-b]pyridine-4-carboxylic acid (93 mg, 0.258 mmol), 3-(aminomethyl)-4,6-dimethyl-2(lH)-pyridinonehydrochloride (64 mg, 0.336 mmol), HOBT (60 mg, 0.387 mmol) and EDC (74 mg, 0.387 mmol) were suspended in DMSO (14 mL) and stirred at room temperature for 10 minutes, after which time DIEA (0.9 ml, 5.16 mmol) was added. After stirring for 2 h, 4- methylmorpholine (1 ml, 9.04 mmol) was added. The reaction mixture was stirred first at room temperature for 21h, and then at 80 C (aluminum heating block) for 3 lh. Thereaction mixture was cooled to room temperature and then added dropwise to a cold,slightly basic solution (pH ~ 8-10) of water (100 mL) and IN Na2C03 (8 mL). Afterstirring for 20 min., the contents were extracted with EtOAc (2 x 100 mL). The combined organic layers are washed with brine, dried over Na2S04, filtered, and concentrated to a residue. The crude residue was dissolved in 10%MeOH/DCM and purified by silica gel chromatography (eluent: 10-95% gradient EtOAc/Hexanes and then 10%(5%NH4OH/MeOH)/DCM and EtOAc, 10-90% gradient). The product was collected as an off-white solid. (35 mg, 27%). LCMS E-S (M+H) = 494.1 / 496.0. 1H NMR (400 MHz, CHLOROFORM-d) delta 11.58 (br. s., 1H), 8.11 (dd, J= 1.89, 7.71 Hz, 2H), 7.68 (br. s., 1H), 7.60 (br. s., 1H), 7.44 - 7.53 (m, 3H), 5.92 (s, 1H), 5.42 (quin, J= 6.69 Hz, 1H), 4.63 (br.s., 1H), 2.41 (br. s., 3H), 2.11 (br. s., 3H), 1.62 (d, J= 6.57 Hz, 6H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dimethyl sulfoxide; at 20℃; for 16h; | Example 124V-[(4,6-Dimethyl-2-oxo-l,2-dihydro-3-pyridinyl)methyl]-l-(l-methylethyl)-6-(2- nitrophenyl)-lH-pyrazolo[3,4-6]pyridine-4-carboxamidel-(l-Methylethyl)-3-nitro-6-phenyl-lH-pyrazolo[3,4-b]pyridine-4-carboxylic acid (24 mg, 0.074 mmol), 3-(aminomethyl)-4,6-dimethyl-2(lH)-pyridinone hydrochloride (18 mg, 0.096 mmol), HO AT (17 mg, 0.110 mmol) and EDC (21 mg, 0.110 mmol) were suspended in DMSO (800 mu?) and the reaction mixture stirred at room temperature. Next added 4-methylmorpholine (41 mu?, 0.368 mmol), and the reaction was stirred at room temperature for 16 h. The reaction mixture was added dropwise to cold, slightly basic solution of water (3 mL) and IN Na2CC"3 (0.5 mL). After stirring for 20 min., the precipitated solids were collected via vacuum filtration and washed with water. The solid was dried on the high vacuum (72 h). The product, was collected as an off- white powder (28 mg, 82%). LCMS E-S (M+H) = 461.1. 1H NMR (400 MHz, DMSO-d6) delta 9.01 (br. s., 1H), 8.42 (s, 1H), 8.02 (ddd, J= 1.14, 4.99, 7.77 Hz, 2H), 7.99 (s, 1H), 7.86 (td, J= 1.26, 7.58 Hz, 1H), 7.72 - 7.77 (m, 1H), 5.90 (s, 1H), 5.04 (quin, J= 6.69 Hz, 1H), 4.41 (d, J = 4.55 Hz, 1H), 3.34 (s, 2H), 2.22 (s, 3H), 2.12 (s, 3H), 1.49 (d, J= 6.57 Hz, 6H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
51% | With 4-methyl-morpholine; benzotriazol-1-ol; 1,2-dichloro-ethane; In dimethyl sulfoxide; at 25℃; for 16h; | To a stirred solution of 5-bromo-3-(sec-butylamino )-2-methylbenzoic acid (1.0 g,5 3.49 mmol), EDC (1.00 g, 5.24 mmol), and HOBT (0.803 g, 5.24 mmol) in dimethylsulfoxide (DMSO) (40 mL) was added N-methylmorpholine (1.537 mL, 13.98 mmol)followed by 3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one, hydrochloride (0.791 g,4.19 mmol). The reaction mixture was stirred at 25 oc for 16 h. The reaction mixture waspoured onto ice water (50 mL), stirred for 10 min, allowed to stand for 10 min, and filtered. The collected solid was rinsed with water (50 mL) followed by 10% MeOH/icewater (50 mL), and then diethyl ether (25mL). The contents were filtered and dried toafford the title compound (750 mg, 51%) as an off-white solid. 1H NMR ( 400 MHz,DMSO-d6) 8 ppm 0.86 (t, 3H, J = 7.5 Hz), 1.10 (d, 3H, J = 6.4 Hz), 1.41-1.48 (m, IH),1.55-1.62 (m, IH), 1.95 (s, 3H), 2.11 (s, 3H), 2.17 (s, 3H), 3.34-3.39 (m, IH), 4.23 (d, 2H, J = 4.9 Hz), 4.65 (d, IH, J = 7.9 Hz), 5.85 (s, IH), 6.55 (s, IH), 6.63 (s, IH), 8.03 (t, IH, J= 4.9 Hz), 11.5 (s, IH). LCMS(ES) [M+H]+ 420.4. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
27% | With 4-methyl-morpholine; benzotriazol-1-ol; 1,2-dichloro-ethane; In dimethyl sulfoxide; at 25℃; for 16h; | To a stirred solution of 5-bromo-3-(isopropyl(methyl)amino )-2-methylbenzoic acid(500 mg, 1.747 mmol), EDC (502 mg, 2.62 mmol), and HOBT (401 mg, 2.62 mmol) in dimethyl sulfoxide (DMSO) (20 mL) was added N-methylmorpholine (0.768 mL, 6.99mmol), followed by <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong> (396mg, 2.097 mmol). The reaction mixture was stirred at 25 oc for 16 h. The reaction mixturewas poured onto ice water (25 mL ), stirred for 10 min, allowed to stand for 10 min, andthen filtered. The collected solid was rinsed with water (25 mL ), followed by 10% MeOH/ice water (15 mL) and diethyl ether (25 mL). The contents were filtered and driedto afford the title compound (200 mg, 27%) as pale organge solid. 1H NMR (400 MHz,DMSO-d6) 8 ppm 1.01 (d, 6H, J = 6.4 Hz), 2.11 (s, 6H), 2.18 (s, 3H), 2.53 (s, 3H), 3.14-3.20 (m, 1H), 4.23 (d, 2H, J = 4.9 Hz), 5.85 (s, 1H), 7.00 (s, 1H), 7.14 (s, 1H), 8.17 (t, 1H,J = 4.9 Hz), 11.5 (s, 1H). LCMS(ES) [M+Ht 420.5. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
27% | With 4-methyl-morpholine; benzotriazol-1-ol; 1,2-dichloro-ethane; In dimethyl sulfoxide; at 25℃; for 16h; | To a stirred solution of 5-bromo-3-(sec-butyl(methyl)amino )-2-methylbenzoic acid(500 mg, 1.666 mmol), EDC (479 mg, 2.498 mmol), and HOBT (383 mg, 2.498 mmol) indimethyl sulfoxide (DMSO) (40 mL) was added N-methylmorpholine (0.732 mL, 6.66mmol), followed by <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong> (377mg, 1.999 mmol). The reaction mixture was stirred at 25 oc for 16 h. The reaction mixture was poured onto ice water (50 mL), stirred for 10 min, allowed to stand for 10 min, andthen filtered. The collected solid was rinsed with water (50 mL), followed by 10%MeOH/ice water (50 mL) and diethyl ether (25 mL). The contents were filtered and dried to afford 400 mg of crude product. The product was purified by silica gel chromatography(eluent: 100% EtOAc) to afford the title compound (200 mg, 27% yield) as an off-whitesolid. 1H NMR (400 MHz, DMSO-d6) 8 ppm 0.83 (t, 3H, J = 7.5 Hz), 0.96 (d, 3H, J = 6.4Hz), 1.41-1.49 (m, 1H), 1.51-1.57 (m, 1H), 2.11 (s, 6H), 2.18 (s, 3H), 2.53 (s, 3H), 2.90-2.96 (m, 1H), 4.23 (d, 2H, J = 4.9 Hz), 5.85 (s, 1H), 6.99 (s, 1H), 7.14 (s, 1H), 8.17 (t, 1H,J = 4.9 Hz), 11.5 (s, 1H). LCMS(ES) [M+Ht 434.5. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1,2-dichloro-ethane; In dichloromethane; at 20℃; for 18h; | To a mixture of 5-bromo-2-methyl-3-(2-methylpyrrolidin-1-yl)benzoic acid (250mg, 0.838 mmol), <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong> salt(160 mg, 0.848 mmol) and HOAt (110 mg, 0.808 mmol) in dichloromethane (DCM) (15 mL) was added N-methylmorpholine (100 )lL, 0.910 mmol), followed by EDC free base(150 mg, 0.966 mmol). The reaction was stirred at room temperature for 18 h. LCMSshowed that the reaction was complete. The reaction was concentrated under vacuum thenpurified by silica gel chromatography (Analogix, SF25-40 g, 0 to 4% MeOH in CH2Cb) togiVe 5-bromo-N -( ( 4,6-dimethyl-2-oxo-1 ,2-dihydropyridin-3-yl)methyl)-2-methyl-3-(2-methylpyrrolidin-1-yl)benzamide (323 mg, 0.747 mmol, 89% yield), after trituration with20% CH2Cb in hexanes, filtration, and drying under vacuum as an off-white solid. 1HNMR (400MHz, DMSO-d6) 8 = 11.48 (s, 1 H), 8.22 (t, J= 4.8 Hz, 1 H), 7.07 (d, J= 2.0Hz, 1 H), 6.93 (d, J = 2.0 Hz, 1 H), 5.86 (s, 1 H), 4.24 (d, J = 5.1 Hz, 2 H), 3.70- 3.58 (m,1 H), 3.53-3.44 (m, 1 H), 2.70 (td, J= 3.8, 8.7 Hz, 1 H), 2.19 (s, 3 H), 2.17-2.12 (m, 1 H), 2.11 (s, 3 H), 2.08 (s, 3 H), 1.92 - 1.80 (m, 1 H), 1.80 - 1.68 (m, 1 H), 1.56 - 1.43 (m, 1H), 0.92 (d, J= 5.8 Hz, 3 H). MS(ES)+ m/e 432.2 [M+H( |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75.0% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1,2-dichloro-ethane; In dichloromethane; at 20℃; for 18h; | To a mixture of 5-bromo-2-methyl-3-(2-methylpiperidin-1-yl)benzoic acid (250mg, 0.801 mmol), <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong> salt(160 mg, 0.848 mmol) and HOAt (110 mg, 0.808 mmol) in dichloromethane (DCM) (15 mL) was added N-methylmorpholine (100 )lL, 0.910 mmol), followed by EDC free base(150 mg, 0.966 mmol). The reaction was stirred at room temperature for 18 h. LCMSshowed that the reaction was complete. The reaction was concentrated under vacuum thenpurified by silica gel chromatography (Analogix, SF25-40 g, 0 to 4% MeOH in CH2Cb) togive 5-bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-3-(2-methylpiperidin-1-yl)benzamide (268 mg, 0.600 mmol, 75.0% yield), after trituration with20% CH2Cb in hexanes, filtration, and drying under vacuum as an off-white solid. 1HNMR (400MHz, DMSO-d6) 8 = 11.48 (s, 1 H), 8.23 (t, J= 4.9 Hz, 1 H), 7.26 (d, J= 1.8Hz, 1 H), 7.09 (d, J= 2.0 Hz, 1 H), 5.86 (s, 1 H), 4.24 (d, J= 5.1 Hz, 2 H), 3.08-2.96 (m,1 H), 2.84 ( d, J = 11.4 Hz, 1 H), 2.49 - 2.39 (m, 1 H), 2.18 (s, 3 H), 2.16 (s, 3 H), 2.11 (s, 3H), 1.81 -1.66 (m, 2 H), 1.64-1.52 (m, 2 H), 1.48-1.25 (m, 2 H), 0.77 (d,J= 6.1 Hz, 3H). MS(ES)+ m/e 446.3 [M+H]+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70.4% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1,2-dichloro-ethane; In dichloromethane; at 20℃; for 3h; | To a mixture of 5-bromo-3-(sec-butoxy)-2-methylbenzoic acid (335 mg, 1.167mmol), <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong> salt (242 mg,1.283 mmol) and HOAt (159 mg, 1.167 mmol) in dichloromethane (DCM) (15 mL) was added N-methylmorpholine (0.141 mL, 1.283 mmol) followed by EDC free base (217 mg,1.400 mmol). The reaction mixture was stirred at RT for 3 hr. The reaction mixture wasconcentrated under vacuum then purified by silica gel chromatography (Analogix, SF25-40 g, 0 to 5% MeOH in CH2Clz; loaded as a suspension in CH2Clz) to give 5-bromo-3-(sec-butoxy)-N-( ( 4,6-dimethyl-2-oxo-1 ,2-dihydropyridin-3-yl)methyl)-2-methylbenzamide (346 mg, 0.821 mmol, 70.4% yield) as a white solid, after triturationwith 5% MeOH in water, filtration, and drying under vacuum. 1 H NMR ( 400MHz,DMSO-d6) 8 = 11.47 (br. s., 1 H), 8.24 (t, J= 4.9 Hz, 1 H), 7.15 (d, J= 1.8 Hz, 1 H), 6.92(d,J= 1.8 Hz, 1 H), 5.86 (s, 1 H), 4.45 (sxt,J= 5.9 Hz, 1 H), 4.24 (d,J= 5.1 Hz, 2 H), 2.18 (s, 3 H), 2.11 (s, 3 H), 2.04 (s, 3 H), 1.70- 1.52 (m, 2 H), 1.21 (d, J= 6.1 Hz, 3 H),0.92 (t, J = 7.5 Hz, 3 H). MS(ES)+ m/e 421.2 [M+H( |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52.1% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1,2-dichloro-ethane; In dichloromethane; at 20℃; for 3h; | To a mixture of 5-bromo-3-isopropoxy-2-methylbenzoic acid ( 430 mg, 1.574mmol), <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong> salt (327 mg,1.732 mmol) and HOAt (214 mg, 1.574 mmol) in dichloromethane (DCM) (15 mL) wasadded N-methylmorpholine (0.190 mL, 1.732 mmol), followed by EDC free base (293mg, 1.889 mmol). The reaction mixture was stirred at RT for 3 hr. The reaction mixturewas concentrated under vacuum then purified by silica gel chromatography (Analogix,SF25-40g, 0 to 5% MeOH in CH2Cb; loaded as a suspension in CH2Cb) to give 5-bromoN-((4,6-dimethyl-2-oxo-1 ,2-dihydropyridin-3-yl)methyl)-3-isopropoxy-2-methylbenzamide (334 mg, 0.820 mmol, 52.1 %yield) as a white solid, after trituration with water, filtration, and drying under vacuum. 1 H NMR ( 400MHz, DMSO-d6) 8 = 11.48(br. s., 1 H), 8.24 (t, J = 4.9 Hz, 1 H), 7.17 (d, J = 1.8 Hz, 1 H), 6.93 (d, J = 1.8 Hz, 1 H),5.86 (s, 1 H), 4.64 (dt, J= 6.0, 12.1 Hz, 1 H), 4.24 (d, J= 5.1 Hz, 2 H), 2.18 (s, 3 H), 2.11(s, 3 H), 2.03 (s, 3 H), 1.26 (d, J= 5.8 Hz, 6 H). MS(ES)+ m/e 407.1 [M+H( |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1,2-dichloro-ethane; In dichloromethane; at 20℃; for 4h; | To a mixture of 5-bromo-3-(N-(sec-butyl)acetamido )-2-methylbenzoic acid (250mg, 0.762 mmol), <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong> salt(160 mg, 0.848 mmol) and HOAt (110 mg, 0.808 mmol) in Dichloromethane (DCM) (15mL) was added N-methylmorpholine (100 )lL, 0.910 mmol) followed by EDC free base(150 mg, 0.966 mmol). The reaction was stirred at room temperature for 4 hr. LCMS showed that the reaction was complete. The reaction was concentrated under vacuum then purified by silica gel chromatography (Analogix, SF25-60g, 0 to 5% MeOH in CH2Cb) togive the product 5-bromo-3 -(N -(sec-butyl )acetamido )-N -( ( 4, 6-dimethyl-2-oxo-1 ,2-dihydropyridin-3-yl)methyl)-2-methylbenzamide (310 mg, 0.670 mmol, 88% yield), aftertrituration with 10% CH2Cb in hexanes, filtration, and drying under vacuum as an off-white solid. 1H NMR (400MHz, DMSO-d6) (amide rotomers) 8 = 11.51 (br. s., 1 H), 8.45(q, J= 5.1 Hz, 1 H), 7.43 (td, J= 2.0, 7.6 Hz, 1 H), 7.34 (d, J= 2.0 Hz, 1 H), 5.87 (s, 1 H),4.49- 4.41 and 4.20-4.16 (2m, 1 H), 4.26 (d, J = 4.8 Hz, 2 H), 2.20 (s, 3 H), 2.12 (s, 3H), 2.09 and 2.07 (2s, 3 H), 1.13 and 0.80 (2d, J = 6.82, 3 H), 0.89 and 0.81 (2t, J = 7.4,3H). MS(ES) [M+Ht 462.2. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
46.0% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1,2-dichloro-ethane; In dichloromethane; at 20℃; for 18h; | To a stirred solution ofmethyl3-(sec-butylamino)-2,5-dichlorobenzoate (I80 mg,0.652 mmol) in methanol (I5 mL) was added IN sodium hydroxide (2.5 mL, 2.500mmol). The reaction was stirred at room temperature over the weekend. LCMS showedthat the reaction was complete. The reaction was evaporated under vacuum to remove themethanol then acidified with IN HCl (2.5 mL). The sticky solid that separated was extracted with CH2Cb, dried (MgS04), filtered and concentrated under vacuum to give thecrude carboxylic acid.To a stirred mixture of the above acid, <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong> salt (135 mg, 0.717 mmol) and HOAt (90 mg, 0.661 mmol) in Dichloromethane (DCM) (20 mL) was added N-methylmorpholine (80 )lL, 0.728 mmol)followed by EDC free base (125 mg, 0.805 mmol). The reaction was stirred at roomtemperature overnight for 18 hr. LCMS showed that the reaction was complete. Thereaction was concentrated under vacuum and purifed by silica gel chromatography(Analogix, SF25-80g, 0 to 4% MeOH in CH2Cb). TLC of the fractions showed a very closely eluting lower spot which partially separated out. The fractions containing whatappeared as pure were combined, evaporated to dryness, triturated with hexanes, filtered,and dried under vacuum to give the product as a white solid. LCMS showed a very closelyeluting impurity that did not separate ( ~ 70% pure). This crude product was re-purified by preparative chiral HPLC on a Chiralcel OJ- H, 5 microns (30 mm x 250 mm) column eluted with (80:20) n-heptane, ethanol. Carriedout 10 prep runs. Collected the pure product fractions and evaporated under vacuum at 50C to a constant weight. The product 3-(sec-butylamino)-2,5-dichloro-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzamide (119 mg, 0.30 mmol, 46.0% yield) wasobtained as a white solid. 1H NMR ( 400MHz, DMSO-d6) 8 = 11.48 (s, 1 H), 8.33 (t, J = 4.9 Hz, 1 H), 6.74 (d, J = 2.3 Hz, 1 H), 6.48 (d, J = 2.3 Hz, 1 H), 5.86 (s, 1 H), 5.12 (d, J =8.6 Hz, 1 H), 4.24 (d, J= 5.1 Hz, 2 H), 3.54-3.43 (m, 1 H), 2.18 (s, 3 H), 2.11 (s, 3 H),1.65- 1.53 (m, 1 H), 1.53- 1.42 (m, 1 H), 1.13 (d, J= 6.3 Hz, 3 H), 0.88 (t, J= 7.3 Hz, 3H). MS(ES) [M+H]+ 396.1.%=% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1,2-dichloro-ethane; In dichloromethane; at 20℃; for 18h; | To a stirred mixture of2,5-dichloro-3-isopropoxybenzoic acid (250 mg, 1.004mmol), 3-(aminomethyl)-4,6-dimethylpyridin-2(IH)-one hydrochloride salt (220 mg,l.I66 mmol) and HOAt (137 mg, 1.004 mmol) in Dichloromethane (DCM) (20 mL) wasadded N-methylmorpholine (130 )lL, I.182 mmol) followed by EDC free base (2IO mg,1.353 mmol). The reaction was stirred at room temperature overnight for I8 hr. LCMSshowed that the reaction was complete. The reaction was concentrated under vacuum and purifed by silica gel chromatography (Analogix, SF25-60g, 0 to 5% MeOH in CH2Cl2) (Not real soluble in CH2Cb.). The pure fractions were combined, evaporated to dryness,triturated with 5% MeOH in water, filtered, washed with water and dried under vacuum togive the product 2,5 -dichloro-N -( ( 4, 6-dimethyl-2-oxo-1 ,2-dihydropyridin-3-yl )methyl)-3-isopropoxybenzamide (340 mg, 0.887 mmol, 88% yield) as a white solid. 1H NMR (400MHz, DMSO-d6) 8 = 11.49 (s, 1 H), 8.41 (t, J= 4.9 Hz, 1 H), 7.29 (d, J= 2.3 Hz, 1H), 6.93 (d, J= 2.3 Hz, 1 H), 5.87 (s, 1 H), 4.76 (dt, J= 6.1, 12.1 Hz, 1 H), 4.25 (d, J= 4.8Hz, 2 H), 2.18 (s, 3 H), 2.11 (s, 3 H), 1.28 (d,J= 6.1 Hz, 6 H). MS(ES) [M+H]+ 383.1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1,2-dichloro-ethane; In dichloromethane; at 20℃; for 18h; | To a stirred mixture of 5-chloro-3-( (1-methoxypropan-2-yl)amino )-2-methylbenzoic acid (400 mg, 1.552 mmol), 3-(aminomethyl)-4,6-dimethylpyridin-2(1H)onehydrochloride salt (300 mg, 1.590 mmol) and HOAt (215 mg, 1.580 mmol) inDichloromethane (DCM) (20 mL) was added N-methylmorpholine (0.18 mL, 1.637mmol) followed by EDC free base (290 mg, 1.868 mmol). The reaction was stirred atroom temperature overnight for 18 hr. LCMS showed that the reaction was complete. The reaction was concentrated under vacuum and purifed by silica gel chromatography(Analogix, SF25-60g, 0 to 5% MeOH in CH2Cb). The pure fractions were combined,evaporated to dryness, triturated with hexanes, filtered, washed with hexanes and driedunder vacuum to give the product 5-chloro-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-( (1-methoxypropan-2-yl)amino )-2-methylbenzamide (561 mg, 1.432 mmol,3%92% yield) as a white solid. 1H NMR (400MHz, DMSO-d6) 8 = 11.47 (s, 1 H), 8.11 (t, J= 4.9 Hz, 1 H), 6.61 (d, J = 2.0 Hz, 1 H), 6.43 (d, J = 2.0 Hz, 1 H), 5.86 (s, 1 H), 4.72 (d, J= 8.3 Hz, 1 H), 4.23 (d, J = 5.1 Hz, 2 H), 3.74- 3.64 (m, 1 H), 3.42- 3.37 (m, 1 H), 3.33(s, 3 H), 3.32-3.29 (m, 1 H), 2.18 (s, 3 H), 2.11 (s, 3 H), 1.96 (s, 3 H), 1.14 (d, J= 6.3 Hz,3 H). MS(ES) [M+Ht 392.2. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1,2-dichloro-ethane; In dichloromethane; at 20℃; for 18h; | To a stirred mixture of 5-chloro-3-isopropoxy-2-methylbenzoic acid (250 mg,1.093 mmol), 3-( aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride salt (230mg, 1.219 mmol) and HOAt (150 mg, 1.102 mmol) in Dichloromethane (DCM) (20 mL)was added N-methylmorpholine (140 )lL, 1.273 mmol) followed by EDC free base (210mg, 1.353 mmol). The reaction was stirred at room temperature overnight for 18 hr.LCMS showed that the reaction was complete. The reaction was concentrated undervacuum and purifed by silica gel chromatography (Analogix, SF25-60g, 0 to 5% MeOH inCH2Clz) (Not real soluble in CH2Clz. Used a DASi filter). The pure fractions were combined, evaporated to dryness, triturated with 5% MeOH in water, filtered, washed withwater and dried under vacuum to give the product 5-chloro-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-isopropoxy-2-methylbenzamide (338 mg, 0.932 mmol, 85% yield) as a white solid.1H NMR (400MHz, DMSO-d6) 8 = 11.48 (s, 1 H), 8.24 (t, J= 4.9 Hz, 1 H), 7.07 (d, J=2.0 Hz, 1 H), 6.80 (d, J = 2.0 Hz, 1 H), 5.86 (s, 1 H), 4.65 (dt, J = 6.0, 12.1 Hz, 1 H), 4.24(d, J= 5.1 Hz, 2 H), 2.18 (s, 3 H), 2.11 (s, 3 H), 2.04 (s, 3 H), 1.26 (d, J= 5.8 Hz, 6 H).MS(ES) [M+Ht 363.1 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1,2-dichloro-ethane; In dichloromethane; at 20℃; for 18h; | To a stirred mixture of 5-chloro-3-( cyclopentyloxy)-2-methylbenzoic acid (250mg, 0.982 mmol), 3-(aminomethyl)-4,6-dimethylpyridin-2(IH)-one hydrochloride salt(200 mg, 1.060 mmol) and HOAt (I40 mg, 1.029 mmol) in Dichloromethane (DCM) (20mL) was added N-methylmorpholine (I20 )lL, 1.09I mmol) followed by EDC free base (I90 mg, 1.224 mmol). The reaction was stirred at room temperature overnight for I8 hr.LCMS showed that the reaction was complete. The reaction was concentrated undervacuum and purifed by silica gel chromatography (Analogix, SF25-60g, 0 to 4% MeOH inCH2Cb) (Not real soluble in CH2Cb. Used a DASi filter). The pure fractions were combined, evaporated to dryness, triturated with 5% MeOH in water, filtered, washed withwater and dried under vacuum to give the product 5-chloro-3-( cyclopentyloxy)-N-(( 4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methylbenzamide (332 mg, 0.854mmol, 87 %yield) as a white solid. 1H NMR ( 400MHz, DMSO-d6) 8 = 11.48 (br. s., 1H), 8.23 (t, J = 4.9 Hz, 1 H), 7.02 (d, J = 1.8 Hz, 1 H), 6.80 (d, J = 2.0 Hz, 1 H), 5.86 (s, 1H), 4.89 (t, J= 5.4 Hz, 1 H), 4.24 (d, J= 5.1 Hz, 2 H), 2.18 (s, 3 H), 2.11 (s, 3 H), 2.02 (s,3 H), 1.93- 1.83 (m, 2 H), 1.76- 1.64 (m, 4 H), 1.63- 1.55 (m, 2 H). MS(ES) [M+Ht389.1 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With 4-methyl-morpholine; 1-hydroxy-7-aza-benzotriazole; 1,2-dichloro-ethane; In dichloromethane; at 20℃; for 18h; | To a stirred mixture of2,5-dichloro-3-(1-methyl-1H-pyrazol-5-yl)benzoic acid (250 mg, 0.922 mmol), <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong>salt (190 mg, 1.007 mmol) and HOAt (130 mg, 0.955 mmol) in Dichloromethane (DCM)(20 mL) was added N-methylmorpholine (110 )lL, 1.001 mmol) followed by EDC freebase (180 mg, 1.159 mmol). The reaction was stirred at room temperature overnight for 18hr. Reaction formed a thick suspension. LCMS showed that the reaction was complete Tried to purifiy by silica gel chromatography (Analogix, SF25-60g, 0 to 10% MeOH inCH2Cb) (Not real soluble in CH2Cl2. Used a DASi filter). Most of the product remainedon the DASi filter. This insoluble material was removed as well as product which streakedoff the column, triturated with 10% MeOH in water, filtered, washed with the same anddried under vacuum to give the product 2,5-dichloro-N-( ( 4,6-dimethyl-2-oxo-1 ,2-dihydropyridin-3-yl)methyl)-3-(1-methyl-1H-pyrazol-5-yl)benzamide (342 mg, 0.844mmol, 92 % yield) as a white solid. The sample for the LCMS was suspended in MeOHwith 1 drop of 6N HCl to dissolve. 1H NMR ( 400MHz, DMSO-d6) 8 = 11.51 (br. s., 1 H),8.57 (t, J = 4.8 Hz, 1 H), 7.60 (d, J = 2.5 Hz, 1 H), 7.55 (d, J = 2.5 Hz, 1 H), 7.52 (d, J =1.8 Hz, 1 H), 6.36 (d, J = 1.8 Hz, 1 H), 5.88 (s, 1 H), 4.29 (d, J = 4.8 Hz, 2 H), 3.64 (s, 3H), 2.20 (s, 3 H), 2.11 (s, 3 H). MS(ES) [M+Ht 405.1 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine; In dimethyl sulfoxide; at 20℃; | To a solution of 5-((1-(tert-butoxycarbonyl)piperidin-4-yl)ethynyl)-3-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-methylbenzoic acid (1.06 g, 2.25 mmol) in DMSO (5.8 mL) at rt was added triethylamine (0.90 mL, 6.44 mmol) and (4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methanaminium chloride (0.405 g, 2.15 mmol). The clear solution become heterogenous. Then HOBT (0.493 g, 3.22 mmol) and EDC (0.617 g, 3.22 mmol) were added and the resulting reaction mixture was stirred at rt overnight. The reaction was quenched with water (80 mL) and the slurry was stirred for 1 h at rt. The slurry was filtrated and the cake was washed with water (2*20 mL). The collected solid was dried under vacuum to give the titled compound (1.27 g, 98% yield). 1H-NMR (500 MHz, CD3OD) 8 ppm; 7.22 (s, 1H), 7.08 (d, J=1.0 Hz 1H), 6.11 (s, 1H), 4.45 (s, 2H), 3.92 (brd, J=10.8 Hz, 2H), 3.78 (dd, J=4.4, 5.4 Hz, 1H), 3.75 (dd, J=4.4, 5.4 Hz, 1H), 3.36 (t, J=11.7 Hz, 2H), 3.21 (br t, J=8.3 Hz, 2H), 3.07 (q, J=7.3 Hz, 2H), 3.01 (dddd, J=3.9, 3.9, 11.3, 11.3 Hz, 1H), 2.84 (dddd, J=3.4, 3.4. 3.9, 3.9 Hz, 1H), 2.38 (s, 3H), 2.28 (s, 3H), 2.25 (s, 3H), 1.88 (m, 2H), 1.70 ((brd, J=12.2 Hz, 2H), 1.60 (m, 4H), 1.47 (s, 9H), 0.87 (t, J=7.3 Hz, 3H); MS (ESI) [M+H]+605.6. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
11% | Ozone was bubbled through a cooled (-78 C.) solution of methyl 3-(propan-2-yloxy)-2-(prop-2-en-1-yloxy)benzoate (123d, 438.1 mg, 1.75 mmol) in dichloromethane (17.5 mL) until a persistent violet-blue color was obtained (about 5 minutes). Nitrogen was bubbled into the solution for 3 minutes, causing the color to fade, then dimethyl sulfide (1.0 mL, 13.5 mmol) was added and the mixture allowed to warm to room temperature for one hour. The solvents were evaporated and the residue partitioned between sodium carbonate solution (sat., aq., 10 mL) and ethyl acetate (2*20 mL). The combined organic extracts were dried over magnesium sulfate, filtered, and concentrated under vacuum to give the crude residue. This crude aldehyde was dissolved in methanol (10.0 mL) and treated with <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong> (Cpd V, 334 mg, 1.87 mmol) at room temperature for five minutes, then sodium cyanoborohydride (332 mg, 4.50 mmol) was added and the mixture stirred at room temperature for 14.5 hours. The solvents were evaporated under vacuum and the residue partitioned between deionized water (10 mL) and ethyl acetate (2*20 mL). The combined organic extracts were dried over magnesium sulfate, filtered, concentrated under vacuum, and purified by column chromatography (EtOH+5% NH4OH in ethyl acetate) to give methyl 2-(2-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]amino}ethoxy)-3-(propan-2-yloxy)benzoate (123e, 76 mg, 11% yield) as a colorless glass. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | To a solution of methyl 3-bromo-2-methyl-6-(2-oxoethoxy)benzoate (126b, 109 mg, 0.380 mmol) in MeOH (5 mL) was added Cpd V (122 mg, 0.538 mmol). The suspension was sonicated until the reaction mixture was homogeneous. The solution was stirred at room temperature for 30 minutes before sodium cyanoborohydride (59 mg, 0.800 mmol) was added in one portion. The reaction mixture was stirred for 3 hours, then the solvent was concentrated in vacuum. The residue was dissolved in DCM (25 mL) and the organic layer washed with water (25 mL). The water layer was extracted with DCM and the combined organic layers were concentrated in vacuum to give methyl 3-bromo-6-(2-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]amino}ethoxy)-2-methylbenzoate (126c, 161 mg, 83%) as a white foam. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; In methanol; at 80℃; for 12h; | To a solution of methyl 2-(bromomethyl)-5-ethoxybenzoate (134c, 0.636 g, 2.33 mmol) and 3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one (Cpd V, 0.390 g, 2.56 mmol) in MeOH (20 mL) was added TEA (0.258 g, 2.56 mmol) at room temperature. The resulting mixture was heated at 80 C. for 12 hours. The reaction mixture was concentrated under vacuum to give the crude product, which was purified by column chromatography (CH2Cl2/MeOH=20:1) and then re-crystallized from MeOH (15 mL) to give the title compound (Example 134, 32.6 mg, 4.4%) as a white solid. 1H NMR (400 MHz, methanol-d4) delta 7.39-7.37 (m, 1H), 7.25 (s, 1H), 7.24-7.14 (m, 1H), 6.09 (s, 1H), 4.73 (s, 2H), 4.33 (s, 2H), 4.09-4.07 (q, 2H), 2.30 (s, 3H), 2.24 (s, 3H), 1.43-1.40 (t, 3H); MS 313.0 [M+1]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With hydrogenchloride; In water; at 100℃; for 6h; | A solution of tert-butyl [(2-methoxy-4,6-dimethylpyridin-3-yl)methyl]carbamate (Cpd U, 140 g, 0.52 mol) in 6N HCl (500 mL) was heated at 100 C. and stirred for six hours. The reaction mixture was concentrated and the residue was re-crystallized with EtOH to afford the title compound (Cpd V, 77 g, 55%) as hydrochloride salts. 1H NMR (400 MHz, D2O) delta 6.31 (s, 1H), 4.11 (s, 2H), 2.31-2.30 (s, 6H); MS 175.1 [M+Na]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
40% | With hydrogenchloride; In 1,4-dioxane; at 20℃; for 4h; | Tert-butyl ((4,6-dimethyl-2-oxo-l,2-dihydropyridin-3-yl)methyl)carbamate (40 g, 0.27 mol)was added into dioxane/HCl (1 L)and the mixture was stirred at room temperature for 4 hr. The reaction solution was filtrated and concentrated to give crude product. The crude was washed with ethyl acetate (lOOmL x 2) and EtOH (50mL x 1) and concentrated to afford the title compound as its HCI salt (15 g, 40 %). LCMS (M + H+) m/z: calc'd. 152.19; found153.1. 1H NMR (DMSO, 400MHz) delta 11.84 (s, 1H), 8.07 (s, 3H), 5.96 (s, 1H), 3.76-7.75(d, J = 5.6 Hz, 2H), 2.21 (s, 3H), 2.15 (s, 3H). |
40% | With hydrogenchloride; In 1,4-dioxane; at 20℃; for 4h; | [00177] Step 3: 3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one: tert-butyl ((4,6- dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamate (40 g, 0.27 mol)was added into dioxane/HCl (1 L)and the mixture was stirred at room temperature for 4 h. The reaction solution was filtrated and concentrated to give crude product. The crude was washed with ethyl acetate (100mL*2) and EtOH (50mL*1) and concentrated to give 3-(aminomethyl)-4,6- dimethylpyridin-2(1H)-one hydrochloride (15 g, 40 %). LCMS (M + H+) m/z: calcd. 152.19;found 153.1. (DMSO, 400MHz) 8 11.84 (s, 1H), 8.07 (s, 3H), 5.96 (s, 1H), 3.76-7.75(d, J =5.6 Hz, 2H), 2.21 (s, 3H), 2.15 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
26% | To a solution of crude compound 6-chloro-7-(l-(l-(2-hydroxy-2- methylpropyl)piperidin-4-yl)ethyl)pyrrolo[l,2-b]pyridazine-5-carboxylic acid (88.75 mg, 0.23 mmol) in anhydrous DMF (2.5 ml) were added l-cyano-2-ethoxy-2- oxoethylidenaminooxy)dimethylamino-morpholino-carbenium hexafluorophosphate (395.6 mg, 0.92 mmol) and N-ethyl-N-isopropylpropan-2-amine (118.7 mg, 0.92 mmol) at room temperature. The reaction mixture was stirred at room temperature for 10 min. Then 3- (aminomethyl)-4,6-dimethylpyridin-2(lH)-one (44mg,0.23mmol) was added at room temperature and the reaction mixture stirred at room temperature for overnight. The reaction was concentrated and the resulting crude product was purified by preparative HPLC (Mobile phase A : water with 0.05% ammonia solution; Mobile phase B : MeCN; column temperature: 30C, Gradient: 50-80% B 10 min) to give 6-chloro-N-((4,6-dimethyl-2-oxo- l,2-dihydropyridin-3-yl)methyl)-7-(l-(l-(2-hydroxy-2-methylpropyl)piperidin-4- yl)ethyl)pyrrolo[l,2-b]pyridazine-5-carboxamide (31.1 mg, 26% yield). LCMS (M+H+) m/z 514. 1H NMR (400 MHz, CHLOROFORM- J) delta 12.15 (s., 1 H), 8.74 (dd, J=9.03, 1.51 Hz, 1 H), 8.11 (dd, J=4.52, 1.51 Hz, 1 H), 7.96 (t, J=5.52 Hz, 1 H), 6.73 (dd, J=9.29, 4.27 Hz, 1 H), 5.94 (s, 1 H), 4.59 (d, J=5.52 Hz, 2 H), 3.32 (s., 1 H), 3.01 (s., 1 H), 2.76 (s., 1 H), 2.41 (s, 4 H), 2.30 (s, 5 H), 2.18 (s., 1 H), 2.11-2.04(m, 1 H), 1.98 (d, J=13.05 Hz, 2 H), 1.40 (d, J=7.03 Hz, 4 H), 1.26 (s, 1 H), 1.12 (s, 3 H), 1.15 (s, 3 H), 1.01 (d, J=12.55 Hz, 1 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
12.1% | With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃;Inert atmosphere; | To a solution of 6-methyl-7-(morpholine-4-carbonyl)pyrrolo[l,2-b]pyridazine- 5-carboxylic acid (96.0 mg, 0.33 mmol) in N,N-dimethylformamide (2.5 mL) was added O- (7-azabenzotriazol-l-yl)-N,N,N,N,-tetramethyluronium (250.8 mg, 0.66 mmol), N,N- diisopropylethylamine (127.7 mg, 0.99 mmol) and 3-(aminomethyl)-4,6-dimethylpyridin-2(lH)-one (150.7 mg, 0.99 mmol). The resulting solution was stirred at room temperature under N2 overnight. The mixture was partitioned between ethyl acetate and water. The organic phase was removed and the aqueous layer was extracted with ethyl acetate. The combined organic layers were washed with brine, dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was subjected to preparatory HPLC for purification to afford N-((4,6-dimethyl-2-oxo- 1 ,2-dihydropyridin-3-yl)methyl)-6-methyl-7-(morpholine-4- carbonyl)pyrrolo[l,2-b]pyridazine-5-carboxamide (17.0 mg, 12.1%) as a light yellow solid. LCMS (M + H+) m/z: calcd. 423.47, found 423.9. 1H NMR (400 MHz, DMSO-d6) delta 11.54 (br.s, 1H), 8.34 - 8.26 (m, 2H), 7.91 - 7.83 (m, 1H), 6.96 - 6.89 (m, 1H), 5.89 (s, 1H), 4.34 - 4.26 (m, 2H), 3.81 - 3.49 (m, 6H), 3.16 - 3.04 (m, 2H), 2.36 (s, 3H), 2.25 (s, 3H), 2.11 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | With triethylamine; HATU; In dichloromethane; at 50℃; for 3h; | To a solution of compound 7-(l-(l-(2-hydroxy-2-methylpropyl)piperidin-4- yl)ethyl)-2,6-dimethylpyrrolo[l,2-b]pyridazine-5-carboxylic acid (15mg, 0.04mmol) and 3- (aminomethyl)-4,6-dimethylpyridin-2(lH)-one (8.5mg, 0.06mmol) in dichloromethane (3 mL) were added compound 0-(7-Azabenzotriazol-l-yl)-N,N,N',N'-tramethyluronium hexafluorophosphate (28 mg, 0.07mmol) and triethylamine (7.4 mg, 0.07 mmol). The reaction mixture was stirred at 50 C for 3 hours. The crude product was purified by preparative HPLC (Mobile phase A : water with 0.05% ammonia solution; Mobile phase B: MeCN; column temperature: 30 C, Gradient: 30-60% B over 10 min) to give product N- ((4,6-dimethyl-2-oxo-l,2-dihydropyridin-3-yl)methyl)-7-(l-(l-(2-hydroxy-2- methylpropyl)piperidin-4-yl)ethyl)-2,6-dimethylpyrrolo[l,2-b]pyridazine-5-carboxamide (12 mg, 63%) as a yellow solid. LCMS (M+H+) calcd. 507.32; found 508.1. 1H NMR (400 MHz, CDC13) delta 0.96-1.07 (m, IH), 1.31-1.32 (d, J=3.2 Hz, 6H), 1.34-1.36 (d, J=7.2 Hz, 4H), 1.94- 2.20 (m, 3H), 2.23 (s, 6H), 2.40-2.43 (m, 8H), 2.49 (s, IH), 2.78 (s, IH), 2.93 (s, 2H), 4.54- 4.56 (d, J=5.6Hz, 2H), 5.94 (s, IH), 6.58 (m, IH), 7.20 (m, lH),8.26-8.28(d, J=9.2Hz, IH). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39.3% | General procedure: Example 4: 3-(Aminomethyl)-6-methyl-4-propylpyridin-2(1 H)-one hydrochloride To a solution of the compound of example 1 (10 g, 56.7 mmol, 1 .0 equiv) in acetic acid (100 ml_), were added 10 % palladium (1 g, 9.40 mmol, 10 % w/w), platinum (IV) oxide (129 mg, 0.553 mmol, 0.01 equiv), and sodium acetate (13.6 g, 166 mmol, 3.0 equiv). The mixture was subjected to hydrogenation under an atmosphere of hydrogen at 80-90 psi for 24 h. This reaction mixture was filtered through celite. The resulting filtrate was concentrated and treated with concentrated HCI and the solid precipitated was filtered. The yellow filtrate obtained was concentrated and cone. HCI and EtOH were added to the crude compound. The reaction mass was stirred at 0 SC for 2 h and the solid obtained was filtered, washed with cold EtOH, diethyl ether and dried to obtain the title compound. Yield: 8.0 g (67 %); 1H NMR (DMSO-d6, 300 MHz): delta 1 1 .88 (s, 1 H), 8.13 (s, 3H), 5.98 (s, 1 H), 3.77 (d, J = 5.4 Hz, 2H), 3.47 (t, J = 6.9 Hz, 2H), 2.16 (s, 3H), 1 .45-1 .52 (m, 2H), 0.90 (t, J = 7.2 Hz, 3H); MS (ESI+): m/z 181 .1 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃; for 48.0h;Inert atmosphere; | Example 18 : N-((4,6-Dimethyl-2-oxo-1 ,2-dihydropyridin-3-yl)methyl)-1 -oxo-2,3-dihydro-1 H- indene-4-carboxamide A mixture of the compound of example 180 (0.200 g, 1 .135 mmol), Hunig's base (0.9 ml_, 5.68 mmol), compound of example 9 (0.300 g, 1 .589 mmol) and DMF (25 ml_) was stirred at ambient temperature in argon atmosphere and HATU (0.691 g, 1 .816 mmol) was added. The mixture was stirred for 48 h. The reaction mixture was concentrated under reduced pressure and the residue obtained was mixed with ice-cool water, solid obtained was filtered to obtain the title compound. Yield: 0.255 g (72 %); 1H NMR (300 MHz, DMSO-d6): delta 1 1 .52 (br. s, 1 H), 8.41 (br. s, 1 H), 7.85 (d, J = 4.5 Hz, 1 H), 7.27 (d, J = 4.5 Hz, 1 H), 7.48 (t, J = 4.5 Hz, 1 H), 5.88 (s, 1 H), 4.32 (d, J = 3.0 Hz, 2H), 3.27 (m, 2H), 2.63 (m, 2H), 2.20 (s, 3H), 2.1 1 (s, 3H); MS (ESI+): m/z 31 1 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃; for 48h;Inert atmosphere; | Example 188: N-((4,6-Dimethyl-2-oxo-1 ,2-dihydropyridin-3-yl)methyl)-1-morpholino-2,3- dihydro-1 H-indene-4-carboxamide A mixture of the compound of example 187 (0.010 g, 0.040 mmol), Hunig's base (0.035 mL, 0.202 mmol), compound of example 9 (0.015 g, 0.081 mmol) and DMF (2.0 mL) was stirred at ambient temperature in argon atmosphere and HATU (0.034 g, 0.089 mmol) was added. The reaction mixture was stirred for 48 h. The mixture was concentrated and the residue obtained was mixed with ice-cool water, solid obtained was filtered to obtain the title compound. Yield: 20 %; 1H NMR (300 MHz, DMSO-d6): delta 12.30 (br. s, 1 H), 7.75 (d, J = 7.5 Hz, 1 H), 7.73 (d, J = 7.5 Hz, 1 H), 7.36 (m, 1 H), 6.22 (s, 1 H), 4.96 (m, 1 H), 4.54 (m, 1 H), 3.98 (s, 3H), 3.50-3.15 (m, 2H), 3.15-2.80 (m, 3H), 2.49-1 .60 (m, 4H), 2.49 (s, 3H), 2.35 (s, 3H), 1 .47-1 .39 (m, 2H); MS (ESI+): m/z 382 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
57% | With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃; for 48h;Inert atmosphere; | Example 189: 6-Bromo-N-((4,6-dimethyl-2-oxo-1 ,2-dihydropyridin-3-yl)methyl)-1-oxo-2,3- dihydro-1 H-indene-4-carboxamide A mixture of 6-bromo-1 -oxo-2,3-dihydro-1 H-indene-4-carboxylic acid (prepared according to the procedure disclosed in WO2005095387A1 ) (0.200 g, 0.141 mmol), Hunig's base (1 .369 mL, 7.84 mmol), compound of example 9 (0.296 g, 1 .568 mmol) and DMF (25 mL) was stirred at ambient temperature in argon atmosphere and HATU (0.691 g, 1 .725 mmol) was added. The reaction mixture was stirred for 48 h. The mixture was concentrated and the residue obtained was mixed with ice-cool water, solid obtained was filtered to obtain the title compound. Yield: 0.178 g (57 %); 1H NMR (300 MHz, DMSO-d6): delta 1 1 .52 (br. s, 1 H), 8.56 (br. s, 1 H), 8.00 (d, J = 1 .8 Hz, 1 H), 7.82 (d, J = 1 .8 Hz, 1 H), 5.87 (s, 1 H), 4.29 (d, J = 4.8 Hz, 2H), 3.23-3.19 (m, 2H), 2.66-2.62 (m, 2H), 2.18 (s, 3H), 2.1 1 (s, 3H); MS (ESI+): m/z 389 (M+H)+ and 391 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
29% | Example 17: tert-Butyl 4-(5-(4-((4,6-dimethyl-2-oxo-1 ,2-dihydropyridin-3-yl)methyl carbamoyl)-1 -isopropylindolin-6-yl)pyridin-2-yl)piperazine-1 -carboxylate To a solution of the compound of example 12 (0.9 g, 1 .873 mmol) in MeOH (25 ml_) and THF (12.50 ml_) was added 1 N NaOH (0.375 g, 9.36 mmol) solution and the resulting mixture was stirred for 16 h at room temperature and for 5 h at 65 SC. After completion of the reaction, the solvent was removed. The solid was subsequently dissolved in DMF (25 ml_) and to this were added 2-(3H- [1 ,2,3]triazolo[4,5-b]pyridin-3-yl)-1 ,1 ,3,3-tetramethylisouronium hexafluorophosphate (V) (1 .068 g, 2.81 mmol) and the compound of example 9 (0.459 g, 2.434 mmol) and stirred at 65 SC for 16 h. After completion of the reaction, water was added to the reaction mixture and the compound was extracted with ethyl acetate. The crude residue was purified by column chromatography (2 % methanol in chloroform) to obtain the compound in crude form. The crude compound was stirred in a mixture of acetone and petroleum ether to obtain the title compound. Yield: 400 mg (29 %); 1 H NMR (DMSO-d6, 300 MHz): delta 1 1 .51 (s, 1 H), 8.45 (s, 1 H), 8.15 (s, 1 H), 7.86 (d, J=7.2 Hz, 1 H), 6.97 (s, 1 H), 6.90 (d, J= 8.7 Hz, 1 H), 6.71 (s, 1 H), 5.86 (s, 1 H), 4.26 (d, J= 3.9 Hz, 2H), 3.96 (m, 1 H), 3.51 (s, 4H), 3.42 (s, 4H), 3.06 (t, J= 7.8 Hz & 7.5 Hz, 2H), 2.17 (s, 3H), 2.10 (s, 3H), 1 .47 (s, 2H), 1 .42 (s, 9H), 1 .08 (d, J=6 Hz, 6H); MS (ESI+): m/z 601 .6 (M+H)+, 623.0 (M+Na)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | N-((4,6-dimethyl-2-oxo-l,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H- pyran-4-yl)amino)-4-methyl-4 '-(morpholinomethyl)- [1,1 '-biphenyl] -3-carboxamide (Compound I)A mixture of 5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'- (morpho linomethyl)-[ 1,1 '-biphenyl] -3 -carboxylic acid (540 g, 1.23 mol) and 3-(aminomethyl)- 4,6-dimethyl-dihydro-pyridin-2(lH)-one hydrochloride (279 g, 1.48 mol) was suspended in DMSO (2.70 L) and treated with triethylamine (223 ml, 1.60 mol). The mixture was stirred at 25 C for 30 min and treated with EDC-HC1 (354 g, 1.85 mol) and HOBT hydrate (283 g, 1.85 mol). The reaction mixture was stirred at rt for 16 h. After addition of triethylamine (292 ml, 2.09 mol), the mixture was cooled to 15 C, diluted with water (10.1 L) maintaining the temperature below 30 C, and stirred at 19-25 C for 4 h. The resulting precipitate was filtered, washed twice with water (2.70 L), and dried under vacuum to give a crude product (695 g, wt-wt analysis = 78%). For the further purification of the product, recrystallization was conducted. A crude product (20.00 g, 34.92 mmol) was suspended in a mixture of ethanol (190 ml) and water (10.00 ml) and heated to 75C until a clear solution was obtained. The solution was allowed to cool to rt overnight. The precipitate was filtered, washed twice with a mixture of ethanol (30.0 ml) and water (30.0 ml), and dried under vacuum at 35 C to give the title compound as an off white solid (14.0 g, 70% recovery from the crude and 90%> yield based on wt-wt assay). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With 1-[(1-(cyano-?2-?ethoxy-?2-?oxoethylidenaminooxy)?dimethylamino-?morpholino)]-uronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 0 - 20℃; for 3h; | A 100 mL round bottom flask was charged with a magnetic stir bar, (R)-2-methyl-1-(1-(tetrahydro-2H-pyran-4-yl)ethyl)-1H-indole-3-carboxylic acid3(1.00 g, 3.48 mmol), <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong> (0.985 g, 5.22 mmol), DMF (8.70 mL, 3.48 mmol), and Hunig?s base (3.04 mL, 17.40 mmol). The reaction was cooled to 0 C and COMU (2.236 g, 5.22 mmol) was added. The reaction was allowed to stir and warm to ambient temperature. After 3 h, the mixture was diluted with water and extracted with EtOAc (2x). The combined organic phases were washed with water, brine, and dried over Na2SO4, filtered and concentrated. The residue was pre-absorbed onto silicagel (30 g) and purified via silica gel chromatogrpahy to afford pure (R)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(tetrahydro-2H-pyran-4-yl)ethyl)-1H-indole-3-carboxamide (1.2 g, 2.79 mmol, 80% yield) as an off-white solid. 1H NMR (400 MHz, DMSO-d6) delta 11.59 (s, 1H), 7.73 (d, J= 7.6 Hz, 1H), 7.65 - 7.58 (m, 2H), 7.12 - 7.01 (m, 2H), 5.89 (s, 1H), 4.31 (t, J= 5.2 Hz, 2H), 4.21 - 4.10 (m, 1H), 3.96 - 3.88 (m, 1H), 3.64 (dd, J= 11.3, 2.8 Hz, 1H), 3.37 - 3.26 (m, 1H), 3.02 (br. s., 1H), 2.58 (s, 3H), 2.47 - 2.38 (m, 1H), 2.26 (s, 3H), 2.12 (s, 3H), 1.82 (br.s., 1H), 1.53 (d, J= 6.7 Hz, 3H), 1.44 - 1.30 (m, 1H), 1.12 - 0.99 (m, 1H), 0.61 (br.s., 1H). LC-MS m/z 422 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With 1-[(1-(cyano-?2-?ethoxy-?2-?oxoethylidenaminooxy)?dimethylamino-?morpholino)]-uronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 0 - 20℃; for 16h; | tert-Butyl (R)-4-(1-(3-(((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamoyl)-2-methyl-1H-indol-1-yl)ethyl)piperidine-1-carboxylate. A round bottomed flask was charged with (R)-1-(1-(1-(tert-butoxycarbonyl)piperidin-4-yl)ethyl)-2-methyl-1H-indole-3-carboxylic acid (3.13 g, 8.10 mmol), <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong> (1.83 g,9.72 mmol), DMF (38 mL), and Hunig?s base (5.66 mL, 32.4mmol). The solution was cooled to 0 C and COMU (5.20 g, 12.1 mmol) was added. The reaction was allowed to stir while warming to room temperature over 16h. The reaction mixture was diluted with half-saturated brine and extracted with EtOAc. The combined organics layer was washed with water, brine, dried over Na2SO4, filtered, and concentrated. The crude residue was purified via silica gel chromatography to afford (R)-4-(1-(3-(((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamoyl)-2-methyl-1H-indol-1-yl)ethyl)piperidine-1-carboxylate (3.48 g, 6.69 mmol, 55%) LC-MZ m/z 521 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
21% | To a solution of l-ethyl-7-methyl-4-(6-(4-methylpiperazin-l-yl)pyridin-3-yl)-lH- indole-6-carboxylic acid (Intermediate 1-15, 70 mg, 0.185 mmol) in DMF (2 mL) was added HATU (105 mg, 0.277 mmol) and stirred at room temperature for 5 minutes. To the reaction mixture was added 3-(aminomethyl)-4,6-dimethylpyridin-2(lH)-one hydrochloride (52.3 mg, 0.277 mmol), TEA (0.038 mL, 0.277 mmol) and stirred at 70 C for 5 hours. After completion of the reaction, the reaction mixture was quenched with water. The solid precipitated was filtered, washed with water and dried. The compound obtained was purified by column using 1-2 % MeOH in chloroform to yield 20 mg (21 ) of the title compound. JH NMR (DMSO-d6, 300 MHz) delta ppm: 8.33 (s, 1H), 8.06 (s, 1H), 7.77(d, J=8.1 Hz, 1H), 7.40(s, 1H), 6.94(d, J=9 Hz, 1H), 6.88(s, 1H), 6.45 (s, 1H), 5.85 (s, 1H), 4.44 (q, J=6.9 Hz, 2H), 4.28 (s, 2H), 3.51 (s, 4H), 2.64 (s, 3H), 2.40 (s, 4H), 2.21 (s, 6H), 2.09 (s, 3H), 1.34 (t, J=6.6 Hz, 3H). MS (ESI+): 513 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
44% | To a solution of 7-methyl-4-(6-(4-methylpiperazin-l-yl)pyridin-3-yl)-l-((tetrahydro-2H- pyran-4-yl)methyl)-lH-indole-6-carboxylic acid (1-28, 80 mg, 0.178 mmol) in DMF (8 mL) was added 2-(3H-[l,2,3]triazolo[4,5-b]pyridin-3-yl)-l,l,3,3-tetramethylisouronium, hexafluoro phosphate(V) salt (102 mg, 0.268 mmol) and stirred at RT for 5 minutes. 3- (Aminomethyl)-4,6-dimethylpyridin-2(lH)-one hydrochloride (43.7 mg, 0.232 mmol) and triethylamine (27.1 mg, 0.268 mmol) were added and stirred the reaction mixture at 65-70 C for 16 h. After completion of the reaction, solvent was removed and the residue was purified by column chromatography (silica gel, 5-10% MeOH in chloroform) to obtain the title compound. Yield: 52 mg (44 %); JH NMR (DMSO-d6; 300 MHz): delta 11.46 (s, 1H), 8.35 (s, 1H), 8.08 (s, 1H), 7.80 (d, J= 6.6 Hz, 1H), 7.39 (d, J= 3 Hz, 1H), 6.99 (d, J= 8.7 Hz, 1H), 6.89 (s, 1H), 6.42 (d, J= 3 Hz, 1H), 5.85 (s, 1H), 4.24-4.30 (m, 5H), 3.80 (d, J= 11.1 Hz, 2H), 3.67 (s, 4H), 3.10-3.20 (m, 4H), 2.83 (s, 4H), 2.63 (s, 3H), 2.20 (s, 3H), 2.09 (s, 3H), 1.85-1.95 (m, 1H), 1.28 (s, 4H); MS (ESI+): 583.2 [M+H]+; HPLC purity: 89.97 %. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39.8% | To a solution of 7-bromo-3-(dimethylamino)-4-methyl-2,3-dihydro-lH-indene-5- carboxylic acid (1-41, 260 mg, 0.872 mmol) in DMF (10 mL) was added HATU (497 mg, 1.308 mmol) and the reaction mass was stirred for 45 minutes. 3-(Aminomethyl)-4,6- dimethylpyridin-2(lH)-one hydrochloride (230 mg, 1.221 mmol) and N-ethyl-N- isopropylpropan-2-amine (0.304 mL, 1.744 mmol) were added and the reaction mass was heated at 50 C for 16 h. On completion of reaction, added water to the reaction mass, extracted using diethyl ether, washed with brine, dried over sodium sulfate, and concentrated to obtain crude, which was purified by column chromatography to obtain the title compound. Yield: 150 mg (39.8 ); JH NMR (DMSO-d6, 300 MHz): delta 11.48 (s, IH), 8.21 (s, IH), 7.25 (s, IH), 5.85 (s, IH), 4.41 (d, IH), 4.22 (bs, 2H), 2.81 (m, 2H), 2.25 (bs, 3H), 2.17 (bs, 4H), 2.09 (bs, 3H), 2.03 (bs, 6H), 1.82 (m,lH); MS (ESI+): m/z 433 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | Add 3-(aminomethyl)-4,6-dimethylpyridin-2(1 H)-one hydrochloride (25.8 g, 137 mmol) and N, N-diisopropylethylamine (65 mL, 373 mmol) to a suspension of 5- [(1 R)- 1- [trans-4-(3 -methoxyazetidin- 1 -yl)cyclohexyl] ethyl] -4-methylthiophene-3 -carboxylic acid(30.5 g, 90.5 mmol) in CH2C12 (400 mL) and stir the mixture for 30 minutes at 23C. Add 1 -(3 -dimethylaminopropyl)3 -ethylcarbodiimide hydrochloride (26.4 g, 138 mmol) and 1 -hydroxybenzotriazole (3.65 g, 27.0 mmol) and stir at 23C for 16 hours. Add water (200 mL) and stir until all the solids dissolve. Separate the layers and wash the organic phase with water (200 mL), saturated aqueous sodium chloride (100 mL), dry over Na2504, filter (wash thoroughly with solvent), and evaporate to dryness. Purify the crude residue by silica gel chromatography eluting with 70/3 0 CH2C12/ACN to which 6% by volume of 2 M NH3 in MeOH is added followed by 6% of 7 N NH3 in MeOH. Combine the appropriate fractions and evaporate to dryness to give a soft off-white solid. Add acetone (400 mL) to the solid and stir for 1.5 hours, filter, and dry at 40C under vacuum to give the title compound (31.6 g, 72%). ES/MS (mlz): 472 (M+H), []2O D -9.95 (c1.0, MeOH), chiral analysis: CHIRALPAK AD (4.6 X 150 mm, 5tM); EtOH (0.2% DMEA); 0.75 mL/min; uv 254 nM; R 6.97 mm; >96% ee. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
14%; 21% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In N,N-dimethyl-formamide; at 23℃; for 6h; | Add 3-(aminomethyl)-4,6-dimethylpyridin-2(1 H)-one hydrochloride (40.3 g, 169 mmol) to a mixture of racemic 5- { 1 -[trans-4-(3 -methoxyazetidin- 1 -yl)cyclohexyl]ethyl} - 4-methylthiophene-3-carboxylic acid (55.0 g, 130 mmol), EDCI (55.0 g, 287 mmol) and HOAt (19.9 g, 143 mmol) in DMF (275 mL) and stir at 23C for 6 hours. Add water (800 mL) and stir the mixture for 30 minutes. Filter, collect the solid, and discard the filtrate. Partition the solid between EtOAc (500 mL) and water (800 mL) and add aqueous 1 M hydrochloric acid until pH 3. Separate the phases and discard the organic phase. Adjust the pH of the aqueous phase with aqueous 1 M sodium hydroxide until pH 8-9,filter the solid and discard the filtrate. Dissolve the solid in CH2C12, dry with MgSO4, filter, and evaporate to dryness. Purify the crude material by silica gel chromatography eluting with a mixture of CH2C12/ACN 70/30 with 5% of 2 M ammonia in MeOH to give the racemic material (33 g, 54%). ES/MS (mlz): 472 (M+H). Collect the mixture fractions and heat in acetone (250 mL) at 500 overnight. Cool to room temperature, filter the solid, and dry under vacuum at 45C to give a solid which is purified by silica gel chromatography eluting with a mixture of CH2C12/ACN 70/30 with 5% of 2 M ammonia in MeOH. Crystallize the isolated material in hot acetone to give racemic material (4.5 g) and combine the isolated lots of racemic material (37.5 g, 60.8%). ES/MS (mlz): 472 (M+H). Separate the racemic material by SFC chiral chromatography using the following conditions: Column: CHIRALPAK AD 5 jtm, 5x25 cm, mobile phase: CO2 with 35% EtOH (2% DMEA), flow rate of 250 glminute, UV 254 mn with analytical conditions of SFC Chiralpck Ad (4.6 x5 jtm), mobile phase 35% EtOH (0.2% DMEA) in C02, 2.5 mL/min, 100 bar outlet pressure at 40 C to give Example 1 (12.7 g, 21%, R2.35 minutes, 94% ee) and Example 2 (8.7 g, 14%, R2.86 minutes, 88% ee). ES/MS (mlz):472 (M+H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
850 mg | Step 7 N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-ethyl-6-(ethyl(tetrahydro-2 H-pyran-4-yl)amino)-2-(1-isopropylpiperidin-4-yl)benzofuran-4-carboxamide The crude 5-ethyl-6-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-(1-isopropylpiperidin-4-yl)benzofu ran-4-carboxylic acid 9f (1.1 g, 2.5 mmol) was dissolved in 20 mL of N,N-dimethylformamide, then 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (715 mg, 3.7 mmol), 1-hydroxybenzotriazole (510 mg, 3.7 mmol) and N,N-diisopropylethylamine (1.6 g, 12.5 mmol) were added. The mixture was stirred 1 hour, then <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong> 2a (470 mg, 2.5 mmol) was added. The mixture was stirred for 16 hours. After the reaction was completed, excess water was added, and the reaction solution was extracted with a mixture of dichloromethane and methanol (V:V=8:1). The organic phases were combined, washed with water and saturated sodium chloride solution, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue was purified by thin-layer chromatography with elution system A to obtain the title compound N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-ethyl-6-(ethyl(tetrahydro-2 H-pyran-4-yl)amino)-2-(1-isopropylpiperidin-4-yl)benzofuran-4-carboxamide 9 (850 mg, yield 59%) as a white solid. MS m/z (ESI): 577.7 [M+1] 1H NMR (400 MHz, DMSO-d6) delta 11.50(s, 1H), 8.16(t, 1H), 7.38(s, 1H), 6.37(brs, 1H), 5.87(s, 1H), 4.31(d, 2H), 3.82(d, 2H), 3.21(t, 2H), 3.01-3.07(m, 4H), 2.91-2.96 (m, 1H), 2.79-2.81(m, 2H), 2.24(s, 3H), 2.17(brs, 2H), 2.12(s, 3H), 2.02(brs, 2H), 1.63-1.66(brd, 2H), 1.45-1.54(m, 2H), 1.25(brs, 6H), 1.01(t, 3H), 0.81(t, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | Step 3 N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-ethyl-6-(ethyl(tetrahydro-2 H-pyran-4-yl)amino)-2-((4-(2-hydroxy-2-methylpropyl)piperazin-1-yl)methyl)benzofur an-4-carboxamide 11 11b (15 mg, 0.031 mmol) was dissolved in 4 mL of N,N-dimethylformamide, then 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (9 mg, 0.046 mmol), 1-hydroxybenzotriazole (7 mg, 0.046 mmol) and N,N-diisopropylethylamine (20 mg, 0.155 mmol) were added to the above reaction solution. The mixture was stirred 1 hour, then 2a (9 mg, 0.046 mmol) was added to the above reaction solution. The mixture was stirred for 12 hours. After the reaction was completed, excess water was added, and the reaction solution was extracted with a mixture of dichloromethane and methanol (V:V=10:1) (10 mL). The organic phases were combined, washed with water (20 mL) and saturated sodium chloride solution (20 mL), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue was purified by thin-layer chromatography with elution system A to obtain the title compound 11 (13 mg, yield 70%) as a white solid. MS m/z (ESI): 622.7 [M+1]1H NMR (400 MHz, DMSO-d6) delta 11.48(brs, 1H), 8.17(t, 1H), 7.39(s, 1H), 6.48(s, 1H), 5.86(s, 1H), 4.32(d, 2H), 4.04(brs,1H), 3.83(brd, 2H), 3.58(s, 2H), 3.21(t, 2H), 3.04(q, 2H), 2.91-2.97(m, 1H), 2.79(q, 2H), 2.56(brs, 4H), 2.45(brs, 4H),2.23(s, 3H), 2.16(brs, 2H), 2.11(s, 3H), 1.63-1.66(m, 2H), 1.48-1.52(m, 2H), 1.00-1.06(m, 9H), 0.82(t, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
18 mg | Step 4 2-Cyclopentyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-ethyl-6-(ethy l(tetrahydro-2H-pyran-4-yl)amino)benzofuran-4-carboxamide 14 14d (15 mg, 0.065 mmol) was dissolved in 4 mL of N,N-dimethylformamide, then 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (20 mg, 0.097 mmol), 1-hydroxybenzotriazole (15 mg, 0.097 mmol) and N,N-diisopropylethylamine (50 mg, 0.33 mmol) were added to the reaction solution. The mixture was stirred 1 hour, then 2a (18 mg, 0.097 mmol) was added. The mixture was stirred for 12 hours. After the reaction was completed, 20 mL of water was added, and the reaction solution was extracted with a mixture of dichloromethane and methanol (V:V=8:1) (10 mL*3). The organic phases were combined, washed successively with water and saturated sodium chloride solution, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue was purified by thin-layer chromatography with elution system A to obtain the title compound 14 (18 mg, yield 53%) as a white solid. MS m/z (ESI): 520.5 [M+1] 1H NMR (400 MHz, DMSO-d6) delta 11.49(brs, 1H), 8.09(s, 1H), 7.35(s, 1H), 6.30(s, 1H), 5.87(s,1H), 4.31(d, 2H), 3.82(brd, 2H), 3.16-3.23(m, 3H), 3.03(q, 2H), 2.90-2.96(m, 1H), 2.79(q, 2H), 2.24(s, 3H), 2.11(s, 3H),2.00(brd, 2H), 1.67(brs, 8H), 1.43-1.53(m, 2H), 1.01(t, 3H), 0.81(t, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
24 mg | Step 6 N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-6-(ethyl(tetrahydro-2H-pyran -4-yl)amino)-5-methyl-2-(1-methylpiperidin-4-yl)benzofuran-4-carboxamide 15 The crude 15e (25 mg, 0.06 mmol) was dissolved in 3 mL of N,N-dimethylformamide, then 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (18 mg, 0.094 mmol), 1-hydroxybenzotriazole (15 mg, 0.094 mmol) and N,N-diisopropylethylamine (40 mg, 0.31 mmol) were added. The mixture was stirred 1 hour, then 2a (18 mg, 0.094 mmol) was added. The mixture was stirred for 12 hours. After the reaction was completed, 20 mL of water was added, and the reaction solution was extracted with a mixture of dichloromethane and methanol. The organic phases were combined, washed successively with water and saturated sodium chloride solution, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue was purified by thin-layer chromatography with elution system A to obtain the title compound 15 (24 mg, yield 73%) as a white solid. MS m/z (ESI): 535.5 [M+1] 1H NMR (400 MHz, DMSO-d6) delta 11.50(brs, 1H), 8.10(s, 1H), 7.34(s, 1H), 6.29(s, 1H), 5.87(s, 1H), 4.31(d, 2H), 3.81(brd,2H), 3.22(t, 2H), 3.03(q, 2H), 2.91-2.94(m, 1H), 2.80(brd, 2H), 2.67(brs, 1H), 2.23(s, 3H), 2.22(s, 3H), 2.18(s, 3H), 2.11(s,3H), 1.92-2.02(m, 4H), 1.61-1.64(m, 4H), 1.45-1.48(m, 2H), 0.78(t, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
750 mg | Example 2 N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-ethyl-6-(ethyl(tetrahydro-2 H-pyran-4-yl)amino)-2-(piperidin-1-ylmethyl)benzofuran-4-carboxamide 5-Ethyl-6-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-(piperidin-1-ylmethyl)benzof uran-4-carboxylic acid 1n (1.0 g, 2.4 mmol) was dissolved in 30 mL of N,N-dimethylformamide, then 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (696 mg, 3.6 mmol), 1-hydroxybenzotriazole (490 mg, 3.6 mmol) and N,N-diisopropylethylamine (1.56 g, 12.1 mmol) were added. The mixture was stirred for 1 hour, then <strong>[1173081-96-3]3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride</strong> 2a (593 mg, 3.0 mmol, prepared by a method disclosed in the patent application "") was added. The mixture was stirred for 12 hours at room temperature. After the reaction was completed, excess water was added, and the reaction solution was extracted with a mixture of dichloromethane and methanol (V:V=8:1). The organic phases were combined, washed with water and saturated sodium chloride solution, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography with elution system A to obtain the title compound N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-ethyl-6-(ethyl(tetrahydro-2 H-pyran-4-yl)amino)-2-(piperidin-1-ylmethyl)benzofuran-4-carboxamide 2 (750 mg, yield 57%) as a white solid. MS m/z (ESI): 549.7 [M+1] 1H NMR (400MHz, DMSO-d6): delta 11.48(s, 1H), 8.15(t, 1H), 7.39(s, 1H), 6.46(s, 1H), 5.86(s, 1H), 4.32(d, 2H), 3.83(d, 2H), 3.54(s, 2H), 3.21(t, 2H), 3.01-3.07(m, 2H), 2.92-2.97(m, 1H), 2.77-2.82(m, 2H), 2.39(brs, 4H), 2.23(s, 3H), 2.11(s, 3H), 1.64-1.67(brd, 2H), 1.47-1.55(m, 6H), 1.36-1.37(brd, 2H), 1.02(t, 3H), 0.82(t, 3H). |
Tags: 1173081-96-3 synthesis path| 1173081-96-3 SDS| 1173081-96-3 COA| 1173081-96-3 purity| 1173081-96-3 application| 1173081-96-3 NMR| 1173081-96-3 COA| 1173081-96-3 structure
A161991[ 771579-27-2 ]
3-(Aminomethyl)-4,6-dimethylpyridin-2(1H)-one
Reason: Free-salt
[ 1860028-30-3 ]
3-(Aminomethyl)-4,6-dimethylpyridin-2(1H)-one dihydrochloride
Similarity: 1.00
[ 771579-27-2 ]
3-(Aminomethyl)-4,6-dimethylpyridin-2(1H)-one
Similarity: 0.98
[ 1346576-04-2 ]
3-(Aminomethyl)-4-ethyl-6-methylpyridin-2(1H)-one hydrochloride
Similarity: 0.96
[ 1346575-64-1 ]
3-(Aminomethyl)-6-methyl-4-propylpyridin-2(1H)-one
Similarity: 0.93
[ 1227465-83-9 ]
5-Amino-4,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carboxamide
Similarity: 0.89
[ 1860028-30-3 ]
3-(Aminomethyl)-4,6-dimethylpyridin-2(1H)-one dihydrochloride
Similarity: 1.00
[ 771579-27-2 ]
3-(Aminomethyl)-4,6-dimethylpyridin-2(1H)-one
Similarity: 0.98
[ 1346576-04-2 ]
3-(Aminomethyl)-4-ethyl-6-methylpyridin-2(1H)-one hydrochloride
Similarity: 0.96
[ 1346575-64-1 ]
3-(Aminomethyl)-6-methyl-4-propylpyridin-2(1H)-one
Similarity: 0.93
[ 1227465-83-9 ]
5-Amino-4,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carboxamide
Similarity: 0.89
[ 1860028-30-3 ]
3-(Aminomethyl)-4,6-dimethylpyridin-2(1H)-one dihydrochloride
Similarity: 1.00
[ 771579-27-2 ]
3-(Aminomethyl)-4,6-dimethylpyridin-2(1H)-one
Similarity: 0.98
[ 1346576-04-2 ]
3-(Aminomethyl)-4-ethyl-6-methylpyridin-2(1H)-one hydrochloride
Similarity: 0.96
[ 1346575-64-1 ]
3-(Aminomethyl)-6-methyl-4-propylpyridin-2(1H)-one
Similarity: 0.93
[ 1227465-83-9 ]
5-Amino-4,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carboxamide
Similarity: 0.89
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :